10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarter Ended October 28, 2023

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to

Commission File No. 1-3083

Genesco Inc.

(Exact name of registrant as specified in its charter)

Tennessee		62-0211340
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)
	535 Marriott Drive	37214
Nashville,	Tennessee	(Zip Code)
(Address of principal executive offices)

Registrant's telephone number, including area code: (615) 367-7000

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $1.00 par value	GCO	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such report), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer; an accelerated filer; a non-accelerated filer; a smaller reporting company; or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ☐ No ☒

As of November 24, 2023, there were 11,489,017 shares of the registrant's common stock outstanding.

INDEX

Part I. Financial Information
Item 1. Financial Statements:
Condensed Consolidated Balance Sheets - October 28, 2023, January 28, 2023 and October 29, 2022	4
Condensed Consolidated Statements of Operations - Three and Nine Months ended October 28, 2023 and October 29, 2022	5
Condensed Consolidated Statements of Comprehensive Income (Loss) - Three and Nine Months ended October 28, 2023 and October 29, 2022	6
Condensed Consolidated Statements of Cash Flows - Nine Months ended October 28, 2023 and October 29, 2022	7
Condensed Consolidated Statements of Equity - Three and Nine Months ended October 28, 2023 and October 29, 2022	8
Notes to Condensed Consolidated Financial Statements	9
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations	15
Item 3. Quantitative and Qualitative Disclosures about Market Risk	22
Item 4. Controls and Procedures	22
Part II. Other Information	23
Item 1. Legal Proceedings	23
Item 1A. Risk Factors	23
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	23
Item 5. Other Information	23
Item 6. Exhibits	24
Signature	25

2

cautionary notice regarding forward-looking statements

Statements in this Quarterly Report on Form 10-Q include certain forward-looking statements, which include statements regarding our intent, belief or expectations and all statements other than those made solely with respect to historical fact. Actual results could differ materially from those reflected by the forward-looking statements in this Quarterly Report on Form 10-Q and a number of factors may adversely affect the forward-looking statements and our future results, liquidity, capital resources or prospects. These include, but are not limited to, adjustments to projections reflected in forward-looking statements, including those resulting from weakness in store and shopping mall traffic, restrictions on operations imposed by government entities and/or landlords, changes in public safety and health requirements and limitations on our ability to adequately staff and operate stores. Differences from expectations could also result from our ability to obtain from suppliers products that are in-demand on a timely basis and effectively manage disruptions in product supply or distribution, including disruptions as a result of pandemics or geopolitical events; the level of consumer spending on our merchandise and interest in our brands and in general; the level and timing of promotional activity necessary to maintain inventories at appropriate levels; our ability to pass on price increases to our customers; the timing and amount of any share repurchases by us; the imposition of tariffs on products imported by us or our vendors as well as the ability and costs to move production of products in response to tariffs; unfavorable trends in fuel costs, foreign exchange rates, foreign labor and material costs; a disruption in shipping or increase in cost of our imported products, and other factors affecting the cost of products; our dependence on third-party vendors and licensors for the products we sell; our ability to renew our license agreements; impacts of the Russia-Ukraine war, and other sources of market weakness in the U.K. and the Republic of Ireland; the effectiveness of our omni-channel initiatives; costs associated with changes in minimum wage and overtime requirements; wage pressure in the U.S. and the U.K.; labor shortages; the effects of inflation; the evolving regulatory landscape related to our use of social media; the establishment and protection of our intellectual property; weakness in the consumer economy and retail industry; competition and fashion trends in our markets, including trends with respect to the popularity of casual and dress footwear; any failure to increase sales at our existing stores, given our high fixed expense cost structure, and in our e-commerce businesses; risks related to the potential for terrorist events; store closures and effects on the business as a result of civil disturbances; changes in buying patterns by significant wholesale customers; changes in consumer preferences; our ability to continue to complete and integrate acquisitions; our ability to expand our business and diversify our product base; impairment of goodwill in connection with acquisitions; payment related risks that could increase our operating cost, expose us to fraud or theft, subject us to potential liability and disrupt our business; retained liabilities associated with divestitures of businesses including potential liabilities under leases as the prior tenant or as a guarantor of certain leases; and changes in the timing of holidays or in the onset of seasonal weather affecting period-to-period sales comparisons. Additional factors that could cause differences from expectations include the ability to secure allocations to refine product assortments to address consumer demand; the ability to renew leases in existing stores and control or lower occupancy costs, to open or close stores in the number and on the planned schedule, and to conduct required remodeling or refurbishment on schedule and at expected expense levels; our ability to realize anticipated cost savings, including rent savings; our ability to make our occupancy costs more variable, realize any anticipated tax benefits in both the amount and timeframe anticipated, and achieve expected digital gains and gain market share; deterioration in the performance of individual businesses or of our market value relative to our book value, resulting in impairments of fixed assets, operating lease right of use assets or intangible assets or other adverse financial consequences and the timing and amount of such impairments or other consequences; unexpected changes to the market for our shares or for the retail sector in general; our ability to meet our sustainability, stewardship, emission and diversity, equity and inclusion related ESG projections, goals and commitments; costs and reputational harm as a result of disruptions in our business or information technology systems either by security breaches and incidents or by potential problems associated with the implementation of new or upgraded systems, and the cost and outcome of litigation, investigations, disputes and environmental matters that involve us. For a full discussion of risk factors, see Item 1A, "Risk Factors".

Readers are cautioned not to place undue reliance on forward-looking statements as such statements speak only as of the date they were made and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements. The most important factors which could cause our actual results to differ from our forward-looking statements are set forth in our description of risk factors in Item 1A contained in our Annual Report on Form 10-K for the fiscal year ended January 28, 2023, which should be read in conjunction with the forward-looking statements in this Quarterly Report on Form 10-Q. Forward-looking statements speak only as of the date they are made, and we do not undertake any obligation to update any forward-looking statement.

The events described in the forward-looking statements might not occur or might occur to a different extent or at a different time than we have described. As a result, our actual results may differ materially from the results contemplated by these forward-looking statements.

We maintain a website at www.genesco.com where investors and other interested parties may obtain, free of charge, press releases and other information as well as gain access to our periodic filings with the Securities and Exchange Commission (“SEC”). The information contained on this website should not be considered to be a part of this or any other report filed with or furnished to the SEC.

3

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements (unaudited)

Genesco Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

(In thousands, except share amounts)

Assets	October 28, 2023			January 28, 2023			October 29, 2022
Current Assets:
Cash and cash equivalents	$	21,691		$	47,990		$	32,113
Accounts receivable, net of allowances of $4,836 at October 28, 2023,
$3,710 at January 28, 2023 and $5,910 at October 29, 2022		56,934			40,818			48,670
Inventories		516,735			458,017			563,490
Prepaids and other current assets		43,350			25,844			37,575
Total current assets		638,710			572,669			681,848
Property and equipment, net		245,009			233,733			221,207
Operating lease right of use assets		459,524			470,991			483,403
Non-current prepaid income taxes		55,632			54,111			52,319
Goodwill		9,283			38,123			37,903
Other intangibles		26,442			27,430			26,208
Deferred income taxes		33,163			28,563			12,168
Other noncurrent assets		25,168			30,806			21,937
Total Assets		1,492,931			1,456,426			1,536,993
Liabilities and Equity
Current Liabilities:
Accounts payable		186,683			144,998			223,404
Current portion - long-term debt		—			—			3,484
Current portion - operating lease liabilities		134,850			134,458			136,294
Other accrued liabilities		75,631			81,327			82,193
Total current liabilities		397,164			360,783			445,375
Long-term debt		128,163			44,858			85,904
Long-term operating lease liabilities		387,347			401,113			413,096
Other long-term liabilities		43,299			42,706			33,275
Total liabilities		955,973			849,460			977,650
Commitments and contingent liabilities		—			—			—
Equity
Non-redeemable preferred stock		812			815			817
Common equity:
Common stock, $1 par value:
Authorized: 80,000,000 shares
Issued common stock		11,991			13,089			13,101
Additional paid-in capital		316,206			305,260			301,692
Retained earnings		269,576			346,870			307,921
Accumulated other comprehensive loss		(43,770	)		(41,211	)		(46,331	)
Treasury shares, at cost (488,464 shares)		(17,857	)		(17,857	)		(17,857	)
Total equity		536,958			606,966			559,343
Total Liabilities and Equity	$	1,492,931		$	1,456,426		$	1,536,993

The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.

4

Genesco Inc. and Subsidiaries

Condensed Consolidated Statements of Operations

(In thousands, except per share amounts)

	Three Months Ended						Nine Months Ended
	October 28, 2023			October 29, 2022			October 28, 2023			October 29, 2022
Net sales	$	579,315		$	603,788		$	1,585,674		$	1,659,868
Cost of sales		300,890			309,981			828,921			860,303
Gross margin		278,425			293,807			756,753			799,565
Selling and administrative expenses		267,474			267,734			778,491			756,318
Goodwill impairment		—			—			28,453			—
Asset impairments and other, net		99			—			581			(154	)
Operating income (loss)		10,852			26,073			(50,772	)		43,401
Other components of net periodic benefit cost		148			50			388			198
Interest expense, net		2,207			906			6,241			1,608
Earnings (loss) from continuing operations before income taxes		8,497			25,117			(57,401	)		41,595
Income tax expense (benefit)		1,908			4,693			(13,483	)		8,551
Earnings (loss) from continuing operations		6,589			20,424			(43,918	)		33,044
Loss from discontinued operations, net of tax		(50	)		(48	)		(98	)		(78	)
Net Earnings (Loss)	$	6,539		$	20,376		$	(44,016	)	$	32,966
Basic earnings (loss) per common share:
Continuing operations	$	0.60		$	1.68		$	(3.87	)	$	2.61
Discontinued operations		0.00			0.00			(0.01	)		0.00
Net earnings (loss)	$	0.60		$	1.68		$	(3.88	)	$	2.61
Diluted earnings (loss) per common share:
Continuing operations	$	0.60		$	1.66		$	(3.87	)	$	2.56
Discontinued operations		0.00			(0.01	)		(0.01	)		0.00
Net earnings (loss)	$	0.60		$	1.65		$	(3.88	)	$	2.56
Weighted average shares outstanding:
Basic		10,898			12,138			11,353			12,637
Diluted		10,972			12,326			11,353			12,901

The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.

5

Genesco Inc. and Subsidiaries

Condensed Consolidated Statements of Comprehensive Income (Loss)

(In thousands)

	Three Months Ended						Nine Months Ended
	October 28, 2023			October 29, 2022			October 28, 2023			October 29, 2022
Net earnings (loss)	$	6,539		$	20,376		$	(44,016	)	$	32,966
Other comprehensive income (loss):
Postretirement liability adjustments, net of tax		62			13			153			76
Foreign currency translation adjustments		(5,800	)		(4,420	)		(2,712	)		(9,999	)
Total other comprehensive loss		(5,738	)		(4,407	)		(2,559	)		(9,923	)
Comprehensive Income (Loss)	$	801		$	15,969		$	(46,575	)	$	23,043

The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.

6

Genesco Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(In thousands)

	Nine Months Ended
	October 28, 2023			October 29, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net earnings (loss)	$	(44,016	)	$	32,966
Adjustments to reconcile net earnings (loss) to net cash used in
operating activities:
Depreciation and amortization		35,449			31,901
Deferred income taxes		(3,929	)		(10,728	)
Goodwill impairment		28,453			—
Impairment of long-lived assets		581			542
Share-based compensation expense		11,107			10,464
Other		1,225			999
Changes in working capital and other assets and liabilities:
Accounts receivable		(16,958	)		(10,224	)
Inventories		(61,086	)		(293,904	)
Prepaids and other current assets		(17,718	)		33,133
Accounts payable		44,551			70,312
Other accrued liabilities		(3,454	)		(45,194	)
Other assets and liabilities		2,255			(64,237	)
Net cash used in operating activities		(23,540	)		(243,970	)
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures		(49,738	)		(39,845	)
Proceeds from asset sales		87			—
Net cash used in investing activities		(49,651	)		(39,845	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Borrowings under revolving credit facility		365,416			212,086
Payments on revolving credit facility		(282,083	)		(136,375	)
Shares repurchased related to share repurchase plan		(32,027	)		(77,470	)
Shares repurchased related to taxes for share-based awards		(2,249	)		(3,942	)
Change in overdraft balances		(1,847	)		4,052
Other		(12	)		2
Net cash provided by (used in) financing activities		47,198			(1,647	)
Effect of foreign exchange rate fluctuations on cash		(306	)		(2,950	)
Net decrease in cash and cash equivalents		(26,299	)		(288,412	)
Cash and cash equivalents at beginning of period		47,990			320,525
Cash and cash equivalents at end of period	$	21,691		$	32,113
Supplemental information:
Interest paid	$	5,711		$	1,276
Income taxes paid		5,487			33,941
Cash paid for amounts included in measurement of operating lease liabilities		130,468			135,116
Operating lease assets obtained in exchange for new operating lease liabilities		111,105			71,598

The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.

7

Genesco Inc. and Subsidiaries

Condensed Consolidated Statements of Equity

(In thousands)

	Non- Redeemable Preferred Stock			Common Stock			Additional Paid-In Capital			Retained Earnings			Accumulated Other Comprehensive Loss			Treasury Shares			Total Equity
Balance January 29, 2022	$	827		$	14,256		$	291,444		$	350,206		$	(36,408	)	$	(17,857	)	$	602,468
Net earnings		—			—			—			4,947			—			—			4,947
Other comprehensive loss		—			—			—			—			(3,817	)		—			(3,817	)
Share-based compensation expense		—			—			3,239			—			—			—			3,239
Restricted stock issuance		—			78			(78	)		—			—			—			—
Shares repurchased		—			(104	)		—			(6,396	)		—			—			(6,500	)
Other		(9	)		(13	)		23			—			—			—			1
Balance April 30, 2022		818			14,217			294,628			348,757			(40,225	)		(17,857	)		600,338
Net earnings		—			—			—			7,643			—			—			7,643
Other comprehensive loss		—			—			—			—			(1,699	)		—			(1,699	)
Share-based compensation expense		—			—			3,549			—			—			—			3,549
Restricted stock issuance		—			239			(239	)		—			—			—			—
Shares repurchased		—			(826	)		—			(44,596	)		—			—			(45,422	)
Restricted shares withheld for taxes		—			(72	)		72			(3,875	)		—			—			(3,875	)
Other		—			(1	)		—			—			—			—			(1	)
Balance July 30, 2022	$	818		$	13,557		$	298,010		$	307,929		$	(41,924	)	$	(17,857	)	$	560,533
Net earnings		—			—			—			20,376			—			—			20,376
Other comprehensive loss		—			—			—			—			(4,407	)		—			(4,407	)
Share-based compensation expense		—			—			3,676			—			—			—			3,676
Restricted shares withheld for taxes		—			(2	)		2			(67	)		—			—			(67	)
Shares repurchased		—			(451	)		—			(20,317	)		—			—			(20,768	)
Other		(1	)		(3	)		4			—			—			—			—
Balance October 29, 2022	$	817		$	13,101		$	301,692		$	307,921		$	(46,331	)	$	(17,857	)	$	559,343
	Non- Redeemable Preferred Stock			Common Stock			Additional Paid-In Capital			Retained Earnings			Accumulated Other Comprehensive Loss			Treasury Shares			Total Equity
Balance January 28, 2023	$	815		$	13,089		$	305,260		$	346,870		$	(41,211	)	$	(17,857	)	$	606,966
Net loss		—			—			—			(18,890	)		—			—			(18,890	)
Other comprehensive income		—			—			—			—			474			—			474
Share-based compensation expense		—			—			3,772			—			—			—			3,772
Restricted stock issuance		—			234			(234	)		—			—			—			—
Restricted shares withheld for taxes		—			(13	)		13			(449	)		—			—			(449	)
Shares repurchased		—			(255	)		—			(8,915	)		—			—			(9,170	)
Other		(3	)		(3	)		6			(78	)		—			—			(78	)
Balance April 29, 2023		812			13,052			308,817			318,538			(40,737	)		(17,857	)		582,625
Net loss		—			—			—			(31,665	)		—			—			(31,665	)
Other comprehensive income		—			—			—			—			2,705			—			2,705
Share-based compensation expense		—			—			4,153			—			—			—			4,153
Restricted stock issuance		—			40			(40	)		—			—			—			—
Shares repurchased		—			(1,006	)		—			(21,851	)		—			—			(22,857	)
Restricted shares withheld for taxes		—			(72	)		72			(1,756	)		—			—			(1,756	)
Other		—			(18	)		17			(185	)		—			—			(186	)
Balance July 29, 2023	$	812		$	11,996		$	313,019		$	263,081		$	(38,032	)	$	(17,857	)	$	533,019
Net earnings		—			—			—			6,539			—			—			6,539
Other comprehensive loss		—			—			—			—			(5,738	)		—			(5,738	)
Share-based compensation expense		—			—			3,182			—			—			—			3,182
Restricted shares withheld for taxes		—			(1	)		1			(44	)		—			—			(44	)
Other		—			(4	)		4			—			—			—			—
Balance October 28, 2023	$	812		$	11,991		$	316,206		$	269,576		$	(43,770	)	$	(17,857	)	$	536,958

The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.

8

Genesco Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (unaudited)

Note 1

Summary of Significant Accounting Policies

Basis of Presentation

These Condensed Consolidated Financial Statements should be read in conjunction with our Consolidated Financial Statements and Notes for Fiscal 2023, which are contained in our Annual Report on Form 10-K as filed with the SEC on March 22, 2023. The Condensed Consolidated Financial Statements and Notes contained in this report are unaudited but reflect all adjustments, including normal recurring adjustments, necessary for a fair presentation of the results for the interim periods of the fiscal year ending February 3, 2024 ("Fiscal 2024"), which is a 53-week year, and of the fiscal year ended January 28, 2023 ("Fiscal 2023"). All subsidiaries are consolidated in the Condensed Consolidated Financial Statements. All significant intercompany transactions and accounts have been eliminated. The results of operations for any interim period are not necessarily indicative of results for the full year. The Condensed Consolidated Financial Statements and the related Notes have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and notes required by U.S. Generally Accepted Accounting Principles (“GAAP”) for complete financial statements. The Condensed Consolidated Balance Sheet as of January 28, 2023 has been derived from the audited financial statements at that date.

Nature of Operations

Genesco Inc. and its subsidiaries (collectively the "Company", "Genesco," "we", "our", or "us") business includes the sourcing and design, marketing and distribution of footwear and accessories through retail stores in the U.S., Puerto Rico and Canada primarily under the Journeys®, Journeys Kidz®, Little Burgundy® and Johnston & Murphy® banners and under the Schuh® banner in the United Kingdom (“U.K.”) and the Republic of Ireland (“ROI”); through e-commerce websites including the following: journeys.com, journeyskidz.com, journeys.ca, littleburgundyshoes.com, schuh.co.uk, schuh.ie, schuh.eu, johnstonmurphy.com, johnstonmurphy.ca, nashvilleshoewarehouse.com and dockersshoes.com as well as catalogs. We also source, design, market and distribute footwear and accessories at wholesale, primarily under our Johnston & Murphy brand, the licensed Levi's® brand, the licensed Dockers® brand, the licensed G.H. Bass® brand and other brands that we license for footwear. At October 28, 2023, we operated 1,360 retail stores in the U.S., Puerto Rico, Canada, the U.K. and the ROI.

During the three and nine months ended October 28, 2023 and October 29, 2022, we operated four reportable business segments (not including corporate): (i) Journeys Group, comprised of the Journeys, Journeys Kidz and Little Burgundy retail footwear chains and e-commerce operations; (ii) Schuh Group, comprised of the Schuh retail footwear chain and e-commerce operations; (iii) Johnston & Murphy Group, comprised of Johnston & Murphy retail operations, e-commerce operations and wholesale distribution of products under the Johnston & Murphy brand; and (iv) Genesco Brands Group, comprised of the licensed Dockers, Levi's, and G.H. Bass brands, as well as other brands we license for footwear.

Selling and Administrative Expenses

Wholesale costs of distribution are included in selling and administrative expenses on the Condensed Consolidated Statements of Operations in the amount of $3.1 million and $3.7 million for the third quarters of Fiscal 2024 and Fiscal 2023, respectively, and $9.1 million and $9.5 million for the first nine months of Fiscal 2024 and Fiscal 2023, respectively.

Retail occupancy costs recorded in selling and administrative expenses were $75.5 million and $77.5 million for the third quarters of Fiscal 2024 and Fiscal 2023, respectively, and $228.3 million and $231.8 million for the first nine months of Fiscal 2024 and Fiscal 2023, respectively.

Advertising Costs

Advertising costs were $33.6 million and $31.3 million for the third quarters of Fiscal 2024 and Fiscal 2023, respectively, and $85.3 million and $81.4 million for the first nine months of Fiscal 2024 and Fiscal 2023, respectively.

Vendor Allowances

Vendor reimbursements of cooperative advertising costs recognized as a reduction of selling and administrative expenses were $2.5 million and $5.0 million for the third quarters of Fiscal 2024 and Fiscal 2023, respectively, and $9.1 million and $11.7 million for the first nine months of Fiscal 2024 and Fiscal 2023, respectively. During the first nine months of each of Fiscal 2024 and Fiscal 2023, our cooperative advertising reimbursements received were not in excess of the costs incurred.

9

Genesco Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (unaudited)

Note 1

Summary of Significant Accounting Policies, Continued

New Accounting Pronouncements

In November 2023, the Financial Accounting Standards Board ("FASB") issued ASU No. 2023-07, "Segment Reporting (Topic 280)". This update provides, among other things, enhanced segment disclosure requirements including disclosures about significant segment expenses. ASU No. 2023-07 is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. We plan to adopt ASU No. 2023-07 on the effective date and do not expect the adoption to have a material impact on our Consolidated Financial Statements.

We continuously monitor and review all current accounting pronouncements and standards from the FASB of U.S. GAAP for applicability to our operations and financial reporting. As of October 28, 2023, there were no other new pronouncements or interpretations that had or were expected to have a significant impact on our financial reporting.

Note 2

Goodwill and Other Intangible Assets

The changes in the carrying amount of goodwill by segment were as follows:

(In thousands)	Journeys Group			Genesco Brands Group			Total Goodwill
Balance, January 28, 2023	$	9,662		$	28,461		$	38,123
Impairment		—			(28,453	)		(28,453	)
Effect of foreign currency exchange rates		(379	)		(8	)		(387	)
Balance, October 28, 2023	$	9,283		$	—		$	9,283

Goodwill Valuation (Genesco Brands Group)

Due to an ongoing dispute with a Genesco Brands Group licensor regarding renewal of their current license in the normal course which has not yet been resolved and based on the requirements of ASC 350, “Intangibles - Goodwill and Other,” we identified indicators of impairment in the second quarter of Fiscal 2024. When indicators of impairment are present on an interim basis, we must assess whether it is "more likely than not" (i.e., a greater than 50% chance) that an impairment has occurred. Due to the identified indicators of impairment in the second quarter of Fiscal 2024, we determined that it was "more likely than not" that an impairment had occurred and performed a full valuation of our Togast reporting unit. Consistent with our annual valuation, our analyses included preparing an income approach and a market approach model. These updated models utilize financial forecasts which exclude cash flows for the disputed license beyond completion of the current contract term. Based upon the results of these analyses, we concluded the goodwill attributed to Togast was fully impaired. As a result, the Company recorded a non-cash impairment charge of $28.5 million in the second quarter of Fiscal 2024.

Other intangibles by major classes were as follows:

	Trademarks				Customer Lists						Other						Total
(In thousands)	Oct. 28, 2023		Jan. 28, 2023		Oct. 28, 2023			Jan. 28, 2023			Oct. 28, 2023			Jan. 28, 2023			Oct. 28, 2023			Jan. 28, 2023
Gross other intangibles	$	23,514	$	24,077	$	6,445		$	6,475		$	400		$	400		$	30,359		$	30,952
Accumulated amortization		—		—		(3,517	)		(3,122	)		(400	)		(400	)		(3,917	)		(3,522	)
Net Other Intangibles	$	23,514	$	24,077	$	2,928		$	3,353		$	—		$	—		$	26,442		$	27,430

10

Genesco Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (unaudited)

Note 3

Inventories

Inventories

(In thousands)	October 28, 2023		January 28, 2023
Wholesale finished goods	$	61,571	$	84,209
Retail merchandise		455,164		373,808
Total Inventories	$	516,735	$	458,017

Note 4

Fair Value

Fair Value of Financial Instruments

The carrying amounts and fair values of our financial instruments at October 28, 2023 and January 28, 2023 are as follows:

Fair Values
(In thousands)	October 28, 2023				January 28, 2023
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
U.S. Revolver Borrowings	$	122,101	$	122,465	$	30,000	$	30,219
U.K. Revolver Borrowings		6,062		6,064		14,858		14,864
Total Long-Term Debt	$	128,163	$	128,529	$	44,858	$	45,083

Debt fair values were determined using a discounted cash flow analysis based on current market interest rates for similar types of financial instruments and would be classified in Level 2 within the fair value hierarchy.

As of October 28, 2023, we have $0.8 million of long-lived assets held and used which were measured using Level 3 inputs within the fair value hierarchy. As of October 28, 2023, we have $5.8 million of investments held and used which were measured using Level 1 inputs within the fair value hierarchy.

Note 5

Earnings Per Share

Weighted-average number of shares used to calculate earnings per share are as follows:

	Three Months Ended				Nine Months Ended
(Shares in thousands)	October 28, 2023		October 29, 2022		October 28, 2023		October 29, 2022
Weighted-average number of shares - basic		10,898		12,138		11,353		12,637
Common stock equivalents		74		188		-		264
Weighted-average number of shares - diluted		10,972		12,326		11,353		12,901

Common stock equivalents of 120,000 shares are excluded for the nine months ended October 28, 2023 due to the loss from continuing operations because to do so would be anti-dilutive.

We did not repurchase any shares during the third quarter of Fiscal 2024. We repurchased 1,261,295 shares during the first nine months of Fiscal 2024 at a cost of $32.0 million, or $25.39 per share. We have $52.1 million remaining as of October 28, 2023 under our expanded share repurchase authorization announced in June 2023. We repurchased 451,343 shares during the third quarter of Fiscal 2023 at a cost of $20.8 million, or $46.01 per share, and repurchased 1,380,272 shares during the first nine months of Fiscal 2023 at a cost of $72.7 million, or $52.66 per share. We accrued $4.8 million of share repurchases in the fourth quarter of Fiscal 2022 due to timing of the cash settlement which is included on the

11

Genesco Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (unaudited)

Note 5

Earnings Per Share, Continued

Condensed Consolidated Statements of Cash Flows for the nine months ended October 29, 2022. During the fourth quarter of Fiscal 2024, through December 6, 2023, we have not repurchased any shares.

Note 6

Long-Term Debt

(In thousands)	October 28, 2023		January 28, 2023
U.S. revolver borrowings	$	122,101	$	30,000
U.K. revolver borrowings		6,062		14,858
Total long-term debt		128,163		44,858
Current portion		—		—
Total Noncurrent Portion of Long-Term Debt	$	128,163	$	44,858

The revolver borrowings outstanding under the Credit Facility as of October 28, 2023 included $117.2 million U.S. revolver borrowings and $4.9 million (C$6.8 million) related to GCO Canada ULC. In addition, revolver borrowings outstanding under the Facility Agreement were $6.1 million (£5.0 million). We were in compliance with all the relevant terms and conditions of the Credit Facility and Facility Agreement as of October 28, 2023. Excess availability under the Credit Facility was $203.4 million at October 28, 2023.

Note 7

Legal Proceedings

Environmental Matters

The Company has legacy obligations including environmental monitoring and reporting costs related to: (i) a 2016 Consent Judgment entered into with the United States Environmental Protection Agency involving the site of a knitting mill operated by a former subsidiary from 1965 to 1969 in Garden City, New York; and (ii) a 2010 Consent Decree with the Michigan Department of Natural Resources and Environment relating to our former Volunteer Leather Company facility in Whitehall, Michigan. We do not expect that future obligations related to either of these sites will have a material effect on our consolidated financial condition or results of operations.

Accrual for Environmental Contingencies

Related to all outstanding environmental contingencies, we had accrued $1.6 million as of October 28, 2023, $1.7 million as of January 28, 2023 and $1.4 million as of October 29, 2022. All such provisions reflect our estimates of the most likely cost (undiscounted, including both current and noncurrent portions) of resolving the contingencies, based on facts and circumstances as of the time they were made. There is no assurance that relevant facts and circumstances will not change, necessitating future changes to the provisions. Such contingent liabilities are included in the liability arising from provision for discontinued operations on the accompanying Condensed Consolidated Balance Sheets because they relate to former facilities operated by us. We have made pretax accruals for certain of these contingencies which were not material for the third quarter of Fiscal 2024 or Fiscal 2023. These charges are included in loss from discontinued operations, net in the Condensed Consolidated Statements of Operations and represent changes in estimates.

In addition to the matters specifically described in this Note, we are a party to other legal and regulatory proceedings and claims arising in the ordinary course of our business. While management does not believe that our liability with respect to any of these other matters is likely to have a material effect on our condensed consolidated financial statements, legal proceedings are subject to inherent uncertainties, and unfavorable rulings could have a material adverse impact on our condensed consolidated financial statements.

Note 8

Commitments

As part of our Genesco Brands Group business, we have a commitment to Samsung C&T America, Inc. (“Samsung”) related to the ultimate sale and valuation of inventories owned by Samsung. If product is sold below Samsung’s cost, we are required to pay to Samsung the difference between the sales price and its cost. At October 28, 2023, the inventory owned by Samsung had a historical cost of $14.4 million. As of October 28, 2023, we believe that we have appropriately accounted for any differences between the fair value of the Samsung inventory and Samsung's historical cost.

12

Genesco Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (unaudited)

Note 9

Business Segment Information

Three Months Ended October 28, 2023
(In thousands)	Journeys Group		Schuh Group		Johnston & Murphy Group			Genesco Brands Group			Corporate & Other			Consolidated
Sales	$	349,367	$	118,129	$	81,414		$	32,907		$	—		$	581,817
Intercompany sales		—		—		(3	)		(2,499	)		—			(2,502	)
Net sales to external customers(1)		349,367		118,129		81,411			30,408			—			579,315
Segment operating income (loss)		11,975		5,484		2,706			(1,560	)		(7,654	)		10,951
Asset impairments and other(2)		—		—		—			—			99			99
Operating income (loss)		11,975		5,484		2,706			(1,560	)		(7,753	)		10,852
Other components of net periodic benefit cost		—		—		—			—			148			148
Interest expense, net		—		—		—			—			2,207			2,207
Earnings (loss) from continuing operations before income taxes	$	11,975	$	5,484	$	2,706		$	(1,560	)	$	(10,108	)	$	8,497
Total assets (3)	$	798,968	$	213,036	$	185,179		$	52,170		$	243,578		$	1,492,931
Depreciation and amortization		8,078		1,566		1,365			265			1,056			12,330
Capital expenditures		8,235		3,380		1,975			710			140			14,440

(1) Net sales in North America and in the U.K., which includes the ROI, accounted for 80% and 20%, respectively, of our net sales in the third quarter of Fiscal 2024.

(2) Asset impairments and other includes a $0.1 million charge for asset impairments in Journeys Group.

(3) Of our $704.5 million of long-lived assets, $87.9 million and $12.9 million relate to long-lived assets in the U.K. and Canada, respectively.

Three Months Ended October 29, 2022
(In thousands)	Journeys Group		Schuh Group		Johnston & Murphy Group		Genesco Brands Group			Corporate & Other			Consolidated
Sales	$	380,619	$	104,809	$	79,614	$	40,661		$	—		$	605,703
Intercompany sales		—		—		—		(1,915	)		—			(1,915	)
Net sales to external customers(1)		380,619		104,809		79,614		38,746			—			603,788
Operating income (loss)		27,083		5,912		3,494		(1,927	)		(8,489	)		26,073
Other components of net periodic benefit cost		—		—		—		—			50			50
Interest expense, net		—		—		—		—			906			906
Earnings (loss) from continuing operations before income taxes	$	27,083	$	5,912	$	3,494	$	(1,927	)	$	(9,445	)	$	25,117
Total assets (2)	$	841,021	$	206,996	$	193,039	$	72,586		$	223,351		$	1,536,993
Depreciation and amortization		6,849		1,485		1,092		214			1,032			10,672
Capital expenditures		4,638		2,405		1,719		370			1,708			10,840

(1) Net sales in North America and in the U.K., which includes the ROI, accounted for 83% and 17%, respectively, of our net sales for the third quarter of Fiscal 2023.

(2) Of our $704.6 million of long-lived assets, $89.3 million and $18.5 million relate to long-lived assets in the U.K. and Canada, respectively.

13

Genesco Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (unaudited)

Note 9

Business Segment Information, Continued

Nine Months Ended October 28, 2023
(In thousands)	Journeys Group			Schuh Group		Johnston & Murphy Group			Genesco Brands Group			Corporate & Other			Consolidated
Sales	$	908,832		$	334,033	$	241,832		$	104,232		$	—		$	1,588,929
Intercompany sales		—			—		(9	)		(3,246	)		—			(3,255	)
Net sales to external customers(1)		908,832			334,033		241,823			100,986			—			1,585,674
Segment operating income (loss)		(21,265	)		12,110		10,178			259			(23,020	)		(21,738	)
Goodwill impairment(2)		-			-		-			-			28,453			28,453
Asset impairments and other(3)		—			—		—			—			581			581
Operating income (loss)		(21,265	)		12,110		10,178			259			(52,054	)		(50,772	)
Other components of net periodic benefit cost		—			—		—			—			388			388
Interest expense, net		—			—		—			—			6,241			6,241
Earnings (loss) from continuing    operations before income taxes	$	(21,265	)	$	12,110	$	10,178		$	259		$	(58,683	)	$	(57,401	)
Depreciation and amortization	$	23,235		$	4,751	$	3,622		$	669		$	3,172		$	35,449
Capital expenditures		32,447			9,376		5,277			1,788			850			49,738

(1) Net sales in North America and in the U.K., which includes the ROI, accounted for 79% and 21%, respectively, of our net sales in the first nine months of Fiscal 2024.

(2) Goodwill impairment of $28.5 million is related to Genesco Brands Group.

(3) Asset impairments and other includes a $0.6 million charge for asset impairments in Journeys Group.

Nine Months Ended October 29, 2022
(In thousands)	Journeys Group		Schuh Group		Johnston & Murphy Group		Genesco Brands Group			Corporate & Other			Consolidated
Sales	$	1,016,396	$	294,486	$	225,448	$	126,442		$	—		$	1,662,772
Intercompany sales		—		—		—		(2,904	)		—			(2,904	)
Net sales to external customers(1)		1,016,396		294,486		225,448		123,538			—		$	1,659,868
Segment operating income (loss)		51,235		5,260		7,256		2,551			(23,055	)	$	43,247
Asset impairments and other(2)		—		—		—		—			(154	)		(154	)
Operating income (loss)		51,235		5,260		7,256		2,551			(22,901	)		43,401
Other components of net periodic benefit cost		—		—		—		—			198			198
Interest expense		—		—		—		—			1,608			1,608
Earnings (loss) from continuing    operations before income taxes	$	51,235	$	5,260	$	7,256	$	2,551		$	(24,707	)	$	41,595
Depreciation and amortization	$	21,060	$	4,607	$	3,271	$	692		$	2,271		$	31,901
Capital expenditures		15,539		6,278		5,528		1,033			11,467			39,845

(1) Net sales in North America and in the U.K., which includes the ROI, accounted for 82% and 18%, respectively, of our net sales for the first nine months of Fiscal 2023.

(2) Asset impairments and other includes a $0.5 million charge for asset impairments, which includes $0.2 million in Journeys Group, $0.2 million in Schuh Group and $0.1 million in Genesco Brands Group, partially offset by a $0.7 million gain on the termination of the pension plan.

14

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

This section discusses management’s view of the financial condition, results of operations and cash flows of the Company. This section should be read in conjunction with the information contained in our Annual Report on Form 10-K for the fiscal year ended January 28, 2023, including the Risk Factors section, and information contained elsewhere in this Quarterly Report on Form 10-Q, including the Condensed Consolidated Financial Statements and notes to those financial statements. The results of operations for any interim period may not necessarily be indicative of the results that may be expected for any future interim period or the entire fiscal year.

Summary of Results of Operations

Our net sales decreased 4.1% to $579.3 million in the third quarter of Fiscal 2024 compared to $603.8 million in the third quarter of Fiscal 2023. The sales decrease compared to last year's third quarter was driven by decreased store sales in Journeys Group and decreased wholesale sales in Genesco Brands Group, partially offset by an 8% increase in comparable e-commerce sales for the total Company and a $7.8 million favorable impact in sales due to changes in foreign exchange rates. Warmer weather in October muted initial demand and delayed the start of the selling season for fall product and our branded businesses were impacted by disruptions related to the implementation of a new ERP system. In addition, ongoing inflationary pressures and economic uncertainty continued to impact discretionary spending behavior. Journeys Group sales decreased 8% and Genesco Brands Group sales decreased 22%, or an aggregate of $8.3 million, while Schuh Group sales increased 13% and Johnston & Murphy Group sales increased 2% for the third quarter of Fiscal 2024 compared to the third quarter of Fiscal 2023. Schuh's sales increased 5% on a local currency basis for the third quarter of Fiscal 2024. Total comparable sales decreased 4% for the third quarter of Fiscal 2024, with same store sales down 7% and comparable direct sales up 8%.

Gross margin decreased 5.2% to $278.4 million in the third quarter of Fiscal 2024 from $293.8 million in the third quarter of Fiscal 2023 and decreased as a percentage of net sales from 48.7% to 48.1%, reflecting decreased gross margin as a percentage of net sales in Journeys Group and Johnston & Murphy Group, partially offset by increased gross margin as a percentage of net sales in Schuh Group and Genesco Brands Group. The overall decrease in gross margin as a percentage of net sales reflects increased promotional activity at Journeys, including introductory coupons for its new loyalty program, more normalized markdowns and closeouts at Johnston & Murphy and increased shipping and warehouse expense in all retail businesses, reflecting increased warehouse costs and higher e-commerce penetration, partially offset by increased gross margin at Schuh reflecting reduced duties and freight from its new Ireland based distribution center as well as a more elevated product mix, and increased gross margin at Genesco Brands reflecting supply chain efficiencies and price increases.

Selling and administrative expenses in the third quarter of Fiscal 2024 were flat on a dollar basis compared to the third quarter of Fiscal 2023 but increased as a percentage of net sales from 44.3% to 46.2%, reflecting increased expenses as a percentage of net sales in all of our operating business units except Johnston & Murphy Group. The overall increase in expenses as a percentage of net sales reflects the deleverage of expenses, especially compensation, marketing and depreciation expenses, as a result of decreased revenue in the third quarter of Fiscal 2024.

Operating margin was 1.9% in the third quarter of Fiscal 2024 compared to 4.3% in the third quarter of Fiscal 2023 reflecting decreased operating margin in all of our operating business units. The decrease in operating margin for the third quarter this year compared to the third quarter last year was impacted by decreased net sales, decreased gross margin as a percentage of sales and increased expenses as percentage of net sales.

Earnings from continuing operations before income taxes (“pretax earnings”) for the third quarter of Fiscal 2024 was $8.5 million compared to $25.1 million for the third quarter of Fiscal 2023. Pretax earnings for the third quarter of Fiscal 2024 included asset impairment and other charges of $0.1 million for asset impairments.

We recorded an effective income tax rate of 22.5% and 18.7% in the third quarter of Fiscal 2024 and Fiscal 2023, respectively. The higher tax rate for the third quarter this year compared to the third quarter last year reflects that we are no longer subject to a valuation allowance in certain jurisdictions.

Net earnings in the third quarter of Fiscal 2024 were $6.5 million, or $0.60 diluted earnings per share, compared to $20.4 million, or $1.65 diluted earnings per share in the third quarter of Fiscal 2023.

Critical Accounting Estimates

We discuss our critical accounting estimates in Item 7, "Management’s Discussion and Analysis of Financial Condition and Results of Operations", in our Annual Report on Form 10-K for the fiscal year ended January 28, 2023. We describe our significant accounting policies in Note 1, "Summary of Significant Accounting Policies", of the Notes to Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended January 28, 2023. There have been no other significant changes in our definition of significant accounting policies or critical accounting estimates since the end of Fiscal 2023.

15

Key Performance Indicators

In assessing the performance of our business, we consider a variety of performance and financial measures. The key performance indicators we use to evaluate the financial condition and operating performance of our business are comparable sales, net sales, gross margin, operating income and operating margin. These key performance indicators should not be considered superior to, as a substitute for or as an alternative to, and should be considered in conjunction with, the U.S. GAAP financial measures presented herein. These measures may not be comparable to similarly titled performance indicators used by other companies.

Comparable Sales

We consider comparable sales to be an important indicator of our current performance, and investors may find it useful as such. Comparable sales results are important to achieve leveraging of our costs, including occupancy, selling salaries, depreciation, etc. Comparable sales also have a direct impact on our total net revenue, cash and working capital. We define "comparable sales" as sales from stores open longer than one year, beginning with the first day a store has comparable sales (which we refer to as "same store sales"), and sales from websites operated longer than one year and direct mail catalog sales (which we refer to in this report as "comparable direct sales"). Temporarily closed stores are excluded from the comparable sales calculation if closed for more than seven days. Expanded stores are excluded from the comparable sales calculation until the first day an expanded store has comparable prior year sales. Current year foreign exchange rates are applied to both current year and prior year comparable sales to achieve a consistent basis for comparison. We have disclosed comparable sales for the third quarter and first nine months of Fiscal 2024 and the third quarter of Fiscal 2023 but did not disclose comparable sales for the first nine months of Fiscal 2023 due to the impact of the COVID-19 pandemic and related extensive store closures during the first quarter of Fiscal 2022. We believe that overall sales is a more meaningful metric during the first nine months of Fiscal 2023.

Results of Operations – Third Quarter of Fiscal 2024 Compared to Third Quarter of Fiscal 2023

Journeys Group

	Three Months Ended
	October 28, 2023			October 29, 2022			% Change
	(dollars in thousands)
Net sales	$	349,367		$	380,619			(8.2	)%
Operating income	$	11,975		$	27,083			(55.8	)%
Operating margin		3.4	%		7.1	%

Net sales from Journeys Group decreased to $349.4 million in the third quarter of Fiscal 2024, compared to $380.6 million in the third quarter of Fiscal 2023 primarily due to a total comparable sales decrease of 8% driven by decreased store sales, partially offset by increased digital sales, and a 3% decrease in the average number of stores in the third quarter this year. We believe the Journeys consumer continues to be pressured by inflation and has chosen to conserve discretionary spending and primarily shop when the consumer has a specific item to purchase, continuing to trade down to lower price points and take advantage of the abundance of discounted athletic product elsewhere in the market. We did see the negative sales trends in the first half of the year sequentially improve in the third quarter this year. The changes we made across product mix resonated with our consumer and sales of high demand, must-have items were strong. However, this was not enough to offset the lack of newness and industry discounting in athletic or the unanticipated late start to fall selling due to the warmer weather in October. Our Journeys store closure plans are on track, with approximately 75% of the 100 planned doors closed through the end of the third quarter, and the remainder targeted to close by the end of Fiscal 2024. Journeys Group operated 1,080 stores at the end of the third quarter of Fiscal 2024, including 224 Journeys Kidz stores, 41 Journeys stores in Canada and 34 Little Burgundy stores in Canada, compared to 1,123 stores at the end of the third quarter of last year, including 230 Journeys Kidz stores, 45 Journeys stores in Canada and 35 Little Burgundy stores in Canada.

Journeys Group had operating income of $12.0 million in the third quarter of Fiscal 2024 compared to $27.1 million in the third quarter of Fiscal 2023. The decrease in operating income for Journeys Group was due to (i) decreased net sales, (ii) decreased gross margin as a percentage of net sales reflecting increased promotional activity, including introductory coupons for its new loyalty program, and increased shipping and warehouse expense and (iii) increased selling and administrative expenses as a percentage of net sales reflecting the deleverage of expenses, especially occupancy, depreciation, marketing and compensation expenses as a result of the decreased revenue in the third quarter of Fiscal 2024.

16

Schuh Group

	Three Months Ended
	October 28, 2023			October 29, 2022			% Change
	(dollars in thousands)
Net sales	$	118,129		$	104,809			12.7	%
Operating income	$	5,484		$	5,912			(7.2	)%
Operating margin		4.6	%		5.6	%

Net sales from Schuh Group increased to $118.1 million in the third quarter of Fiscal 2024 compared to $104.8 million in the third quarter of Fiscal 2023, primarily due to increased total comparable sales of 5% driven by a healthy back-to-school season with increased e-commerce and store sales and a favorable impact of $8.4 million in sales due to changes in foreign exchange rates. Schuh was impacted by a later start to fall selling due to the warmer weather in October. The strength of the Schuh business is broad based across stores and digital as their digital business continues to account for almost 40% of its sales in the third quarter of Fiscal 2024. Schuh's sales increased 5% on a local currency basis for the third quarter of Fiscal 2024. Schuh Group operated 124 stores at the end of the third quarter of Fiscal 2024, compared to 122 stores at the end of the third quarter of Fiscal 2023.

Schuh Group had operating income of $5.5 million in the third quarter of Fiscal 2024 compared to $5.9 million in the third quarter of Fiscal 2023. The decrease in operating income compared to last year reflects increased selling and administrative expenses as a percentage of net sales, reflecting increased performance-based compensation and compensation expenses and selling salaries, partially offset by decreased occupancy expense. In addition, operating income included a favorable impact of $0.4 million due to changes in foreign exchange rates compared to last year. Gross margin increased as a percentage of net sales reflecting reduced duties and freight from its new Ireland based distribution center as well as a more elevated product mix, which was partially offset by increased shipping and warehouse expense, reflecting higher e-commerce penetration and increased warehouse costs..

Johnston & Murphy Group

	Three Months Ended
	October 28, 2023			October 29, 2022			% Change
	(dollars in thousands)
Net sales	$	81,411		$	79,614			2.3	%
Operating income	$	2,706		$	3,494			(22.6	)%
Operating margin		3.3	%		4.4	%

Johnston & Murphy Group net sales increased to $81.4 million for the third quarter of Fiscal 2024 from $79.6 million for the third quarter of Fiscal 2023, primarily due to a 1% increase in comparable sales, reflecting increased e-commerce sales and wholesale sales, partially offset by decreased store sales. Johnston & Murphy sales for the third quarter of Fiscal 2024 were impacted by the implementation of a new ERP system along with warmer weather in October that delayed the start to the fall selling season. Johnston & Murphy has repositioned its business as a multi-category lifestyle brand. The brand's casual category as well as apparel and accessories continued to resonate well with its consumers. Retail operations accounted for 72.5% of Johnston & Murphy Group's sales in the third quarter of Fiscal 2024, down from 72.9% in the third quarter of Fiscal 2023. The store count for Johnston & Murphy retail operations at the end of the third quarter of Fiscal 2024 was 156 stores, including six stores in Canada, compared to 159 stores, including six stores in Canada, at the end of the third quarter of Fiscal 2023.

Johnston & Murphy Group had operating income of $2.7 million for the third quarter of Fiscal 2024 compared to $3.5 million in the third quarter of Fiscal 2023. The decrease in operating income compared to last year reflects decreased gross margin as a percentage of net sales, reflecting more normalized markdowns and closeouts and increased shipping and warehouse expense, reflecting increased warehouse costs. Selling and administrative expenses decreased as a percentage of net sales for the third quarter of Fiscal 2024, reflecting decreased performance-based compensation expense and occupancy expense, partially offset by increased marketing expense.

Genesco Brands Group

	Three Months Ended
	October 28, 2023			October 29, 2022			% Change
	(dollars in thousands)
Net sales	$	30,408		$	38,746			(21.5	)%
Operating loss	$	(1,560	)	$	(1,927	)		19.0	%
Operating margin		(5.1	)%		(5.0	)%

17

Genesco Brands' net sales decreased to $30.4 million for the third quarter of Fiscal 2024 from $38.7 million for the third quarter of Fiscal 2023 primarily due to an intentional strategy to pull back value channel sales.

Genesco Brands' operating loss improved to $1.6 million in the third quarter of Fiscal 2024 compared to $1.9 million in the third quarter of Fiscal 2023. The $0.4 million smaller operating loss was primarily due to increased gross margin as a percentage of net sales reflecting supply chain efficiencies and price increases. Selling and administrative expenses increased as a percentage of net sales in the third quarter of Fiscal 2024 reflecting the deleverage of expenses as a result of decreased revenue in the third quarter this year, partially offset by decreased royalty, marketing and other expenses.

Corporate, Interest Expenses and Other Charges

Corporate and other expense for the third quarter of Fiscal 2024 was $7.8 million compared to $8.5 million for the third quarter of Fiscal 2023. Corporate expense in the third quarter of Fiscal 2024 included $0.1 million charge in asset impairment and other charges for asset impairments. The corporate expense decrease, excluding asset impairment and other charges, primarily reflects a decrease in miscellaneous expenses in the third quarter this year compared to the third quarter last year.

Net interest expense increased $1.3 million to $2.2 million in the third quarter of Fiscal 2024 compared to net interest expense of $0.9 million in the third quarter of Fiscal 2023 primarily reflecting increased average borrowings and higher interest rates in the third quarter this year compared to the third quarter last year.

Results of Operations – Nine Months of Fiscal 2024 Compared to Nine Months of Fiscal 2023

Our net sales decreased 4.5% to $1.586 billion in the first nine months of Fiscal 2024 compared to $1.660 billion in the first nine months of Fiscal 2023. The sales decrease compared to last year's first nine months was driven by decreased store sales in Journeys Group and decreased wholesale sales, partially offset by a 10% increase in comparable e-commerce sales for the total Company, strong store performance at Schuh and Johnston & Murphy and a favorable impact of $2.6 million in sales due to changes in foreign exchange rates. Ongoing inflationary pressures and economic uncertainty continue to impact the discretionary spending behavior of our consumers. Journeys Group sales decreased 11% and Genesco Brands Group sales decreased 18%, or an aggregate of $22.6 million, while Schuh Group sales increased 13% and Johnston & Murphy Group sales increased 7% for the first nine months of Fiscal 2024 compared to the first nine months of Fiscal 2023. Schuh's sales increased 11% on a local currency basis for the first nine months of Fiscal 2024. Total comparable sales decreased 4% for the first nine months of Fiscal 2024, with same store sales down 7% and comparable direct sales up 10%.

Gross margin decreased 5.4% to $756.8 million in the first nine months of Fiscal 2024 from $799.6 million in the first nine months of Fiscal 2023 and decreased as a percentage of net sales from 48.2% to 47.7%, reflecting decreased gross margin as a percentage of net sales in Journeys Group, partially offset by an increase in gross margin as a percentage of net sales in all of our other operating business units. The overall decrease in gross margin as a percentage of net sales reflects increased promotional activity at Journeys and increased shipping and warehouse expense at Journeys and Johnston & Murphy, primarily reflecting increased warehouse costs, partially offset by a more elevated product mix at Schuh as well as reduced duties and freight from the new Ireland based distribution center, decreased air freight at Johnston & Murphy and supply chain efficiencies, favorable changes in product mix and increased prices at Genesco Brands.

Selling and administrative expenses in the first nine months of Fiscal 2024 increased 2.9% and increased as a percentage of net sales from 45.6% to 49.1%, reflecting increased expenses as a percentage of net sales in all operating business units except Johnston & Murphy Group. The overall increase in expenses as a percentage of net sales reflects the deleverage of expenses, especially compensation expense, marketing expense, occupancy expense and selling salaries as a result of decreased revenue in the first nine months of Fiscal 2024. Explanations of the changes in results of operations are provided by business segment in discussions following these introductory paragraphs.

The pretax loss for the first nine months of Fiscal 2024 was $57.4 million compared to pretax earnings of $41.6 million for the first nine months of Fiscal 2023. The pretax loss for the first nine months of Fiscal 2024 included a non-cash goodwill impairment charge of $28.5 million and asset impairment and other charges of $0.6 million for asset impairments. Pretax earnings for the first nine months of Fiscal 2023 included an asset impairment and other gain of $0.2 million for a $0.7 million gain on the termination of the pension plan, partially offset by $0.5 million in asset impairments.

We recorded an effective income tax rate of 23.5% in the first nine months of Fiscal 2024 compared to 20.6% in the first nine months of Fiscal 2023. The higher tax rate for the first nine months this year compared to the same period last year reflects that we are no longer subject to a valuation allowance in certain jurisdictions.

The net loss in the first nine months of Fiscal 2024 was $44.0 million, or $3.88 diluted loss per share, compared to net earnings in the first nine months of Fiscal 2023 of $33.0 million, or $2.56 diluted earnings per share.

18

Journeys Group

	Nine Months Ended
	October 28, 2023			October 29, 2022			% Change
	(dollars in thousands)
Net sales	$	908,832		$	1,016,396			(10.6	)%
Operating income (loss)	$	(21,265	)	$	51,235		NM
Operating margin		(2.3	)%		5.0	%

Net sales from Journeys Group decreased to $908.8 million in the first nine months of Fiscal 2024, compared to $1.016 billion in the first nine months of Fiscal 2023 primarily due to a total comparable sales decrease of 10% driven by decreased store sales, partially offset by increased digital sales, and a 2% decrease in the average number of stores in the first nine months this year. We believe the Journeys consumer continues to be pressured by inflation and has chosen to conserve discretionary spending and primarily shop when the consumer has a specific item to purchase, continuing to trade down to lower price points and take advantage of the abundance of discounted athletic product elsewhere in the market. While we made changes to our product mix in the third quarter of Fiscal 2024, we will continue to work with our brands to reposition our product assortment at Journeys to meet the customer's appetite for newness.

Journeys Group had an operating loss of $21.3 million in the first nine months of Fiscal 2024 compared to operating income of $51.2 million in the first nine months of Fiscal 2023. The $72.5 million decrease in operating income for Journeys Group was due to (i) decreased net sales, (ii) decreased gross margin as a percentage of net sales primarily reflecting increased promotional activity and (iii) increased selling and administrative expenses as a percentage of net sales reflecting the deleverage of expenses, especially occupancy expense, selling salaries and compensation expense as a result of the decreased revenue in the first nine months of Fiscal 2024.

Schuh Group

	Nine Months Ended
	October 28, 2023			October 29, 2022			% Change
	(dollars in thousands)
Net sales	$	334,033		$	294,486			13.4	%
Operating income	$	12,110		$	5,260			130.2	%
Operating margin		3.6	%		1.8	%

Net sales from Schuh Group increased to $334.0 million in the first nine months of Fiscal 2024 compared to $294.5 million in the first nine months of Fiscal 2023, primarily due to increased total comparable sales of 11% driven by increased e-commerce and store sales and a favorable impact of $5.7 million in sales due to changes in foreign exchange rates. Schuh's sales increased 11% on a local currency basis for the first nine months of Fiscal 2024.

Schuh Group had operating income of $12.1 million in the first nine months of Fiscal 2024 compared to $5.3 million in the first nine months of Fiscal 2023. The increase in operating income for Schuh Group reflects (i) increased net sales and (ii) increased gross margin as a percentage of net sales reflecting an elevated product mix and reduced duties and freight as a result of the new Ireland based distribution center. In addition, operating income included a favorable impact of $0.9 million due to changes in foreign exchange rates compared to last year. Selling and administrative expenses as a percentage of net sales increased slightly, reflecting increased selling salaries and performance-based compensation expense, partially offset by decreased occupancy expense.

Johnston & Murphy Group

	Nine Months Ended
	October 28, 2023			October 29, 2022			% Change
	(dollars in thousands)
Net sales	$	241,823		$	225,448			7.3	%
Operating income	$	10,178		$	7,256			40.3	%
Operating margin		4.2	%		3.2	%

Johnston & Murphy Group net sales increased to $241.8 million for the first nine months of Fiscal 2024 from $225.4 million for the first nine months of Fiscal 2023, primarily due to a 10% increase in comparable sales, with increases in both store sales and e-commerce sales, partially offset by decreased wholesale sales. Johnston & Murphy has repositioned the brand to offer more casual and comfortable footwear and apparel, and it continues to resonate well with its consumers. Retail operations accounted for 75.4% of Johnston & Murphy Group's sales in the first nine months of Fiscal 2024, up from 73.0% in the first nine months of Fiscal 2023.

19

Johnston & Murphy Group had operating income of $10.2 million for the first nine months of Fiscal 2024 compared to $7.3 million in the first nine months of Fiscal 2023. The increase was primarily due to (i) increased net sales, (ii) increased gross margin as a percentage of net sales reflecting a decrease in air freight, partially offset by increased warehouse costs, retail markdowns and increased inventory reserves and (iii) decreased selling and administrative expenses reflecting greater leverage of expenses as a result of revenue growth, especially occupancy expense and performance-based compensation, partially offset by increased marketing and compensation expenses.

Genesco Brands Group

	Nine Months Ended
	October 28, 2023			October 29, 2022			% Change
	(dollars in thousands)
Net sales	$	100,986		$	123,538			(18.3	)%
Operating income	$	259		$	2,551			(89.8	)%
Operating margin		0.3	%		2.1	%

Genesco Brands' net sales decreased to $101.0 million for the first nine months of Fiscal 2024 from $123.5 million for the first nine months of Fiscal 2023 primarily due to higher sell-in in the first half of the prior year as retailers were replenishing inventory due to supply chain constraints as well as an intentional strategy to pull back value channel sales.

Genesco Brands' operating income decreased to $0.3 million in the first nine months of Fiscal 2024 compared to $2.6 million in the first nine months of Fiscal 2023. The decrease in operating income was primarily due to (i) decreased net sales and (ii) increased selling and administrative expenses as a percentage of net sales in the first nine months of Fiscal 2024 reflecting deleverage of expenses as a result of decreased revenue in the first nine months of Fiscal 2024. Gross margin increased as a percentage of net sales for the first nine months of Fiscal 2024 reflecting supply chain efficiencies, changes in product mix and price increases.

Corporate, Interest Expenses and Other Charges

Corporate and other expense for the first nine months of Fiscal 2024 was $52.1 million compared to $22.9 million for the first nine months of Fiscal 2023. Corporate expense in the first nine months of Fiscal 2024 included non-cash impairment charges of $28.5 million related to goodwill and a $0.6 million charge in asset impairment and other charges for asset impairments. Corporate expense in the first nine months of Fiscal 2023 included a $0.2 million gain in asset impairment and other charges for a gain on the termination of the pension plan, partially offset by asset impairments.

Net interest expense increased $4.6 million to $6.2 million in the first nine months of Fiscal 2024 compared to net interest expense of $1.6 million in the first nine months of Fiscal 2023 primarily reflecting increased average borrowings and higher interest rates in the first nine months this year compared to the first nine months last year.

Liquidity and Capital Resources

Working Capital

Our business is seasonal, with our investment in working capital normally reaching peaks in the summer and fall of each year in anticipation of the back-to-school and holiday selling seasons. Historically, cash flows from operations typically have been generated principally in the fourth quarter of each fiscal year.

	Nine Months Ended
Cash flow changes:	October 28, 2023			October 29, 2022			Increase (Decrease)
(in thousands)
Net cash used in operating activities	$	(23,540	)	$	(243,970	)	$	220,430
Net cash used in investing activities		(49,651	)		(39,845	)		(9,806	)
Net cash provided by (used in) financing activities		47,198			(1,647	)		48,845
Effect of foreign exchange rate fluctuations on cash		(306	)		(2,950	)		2,644
Net decrease in cash and cash equivalents	$	(26,299	)	$	(288,412	)	$	262,113

20

Reasons for the major variances in cash used in the table above are as follows:

Cash used in operating activities was $220.4 million lower in the first nine months of Fiscal 2024 compared to the first nine months of Fiscal 2023, reflecting primarily the following factors:

•a $232.8 million increase in cash flow from changes in inventory, primarily reflecting the re-inventorying of our operating business units in the first nine months last year due to the supply chain disruptions in Fiscal 2023 compared to a much smaller increase in inventory, primarily retail inventory, in the first nine months this year, partially offset by a $25.8 million decrease in cash flow from changes in accounts payable, primarily reflecting changes in buying patterns in the first nine months of Fiscal 2024 and the decrease in inventory growth year over year; and

•a $41.7 million increase in cash flow from changes in other accrued liabilities, primarily reflecting a significantly lower payment of Fiscal 2023 performance-based compensation accruals in the first nine months of Fiscal 2024 compared to the first nine months of Fiscal 2023; partially offset by

•a $77.0 million decrease in net earnings, which was partially offset by a $28.5 million non-cash goodwill impairment charge.

Cash used in investing activities was $9.8 million higher for the first nine months of Fiscal 2024 as compared to the first nine months of Fiscal 2023 reflecting increased capital expenditures primarily related to investments in retail stores and omni-channel as a result of catching up from the pause due to COVID, partially offset by decreased capital expenditures related to the new corporate headquarters building.

Cash provided by financing activities was $48.8 million higher in the first nine months of Fiscal 2024 as compared to the first nine months of Fiscal 2023 reflecting increased net borrowings and decreased share repurchases this year compared to the same period last year.

Sources of Liquidity and Future Capital Needs

We have three principal sources of liquidity: cash flow from operations, cash and cash equivalents on hand and our credit facilities discussed in Item 8, Note 8, "Long-Term Debt", to our Consolidated Financial Statements included in our Annual Report on Form 10-K for Fiscal 2023.

As of October 28, 2023, we have borrowed $117.2 million U.S. revolver borrowings, $4.9 million (C$6.8 million) related to GCO Canada ULC and $6.1 million (£5.0 million) U.K. revolver borrowings. We were in compliance with all the relevant terms and conditions of the Credit Facility and the Facility Agreement as of October 28, 2023.

We believe that cash on hand, cash provided by operations and borrowings under our Credit Facility and the Facility Agreement will be sufficient to support our liquidity needs in Fiscal 2024 and the foreseeable future.

During the second quarter of Fiscal 2024, in light of store traffic trends and general consumer uncertainty, we identified approximately 100 Journeys stores for closure in Fiscal 2024. Our Journeys store closure plans are on track, with approximately 75% of the 100 planned doors closed through the end of the third quarter, and the remainder targeted to close by the end of Fiscal 2024. We are continuing our efforts in making occupancy costs more variable. In addition, we are continuing to conduct a holistic review of our cost structure. We expect to realize significant cost savings in Fiscal 2024 and Fiscal 2025. We expect that a significant portion of these savings will be realized by our Journeys Group.

In the fourth quarter of Fiscal 2021, we implemented tax strategies allowed under the 5-year carryback provisions in the CARES Act which we believe will generate approximately $55 million of net tax refunds. We received approximately $26 million of such net tax refunds in Fiscal 2022 and anticipated receipt of the remaining outstanding net tax refund in Fiscal 2023. However, in the third quarter of Fiscal 2023, we were notified the IRS would conduct an audit of the periods related to the outstanding net tax refund. While we do not believe any uncertainty with the technical merits of the positions generating the net tax refunds exists, we do anticipate the timing of the net tax refund will be extended as a result of the audit process. Accordingly, we have recorded the outstanding refund to non-current prepaid income taxes on the Condensed Consolidated Balance Sheets as of October 28, 2023.

Contractual Obligations

Our contractual obligations at October 28, 2023 decreased 2% compared to January 28, 2023, primarily due to decreased lease obligations and purchase obligations, partially offset by increased long-term debt.

Capital Expenditures

Total capital expenditures in Fiscal 2024 are expected to be approximately $55 million to $60 million of which approximately 57% is for new stores and remodels and 43% is for computer hardware, software and warehouse enhancements for initiatives to drive traffic and omni-channel capabilities. We do not currently have any longer-term capital expenditures or other cash requirements other than as set forth above and in the contractual obligations table as disclosed in Item 7 of our Fiscal 2023 Form 10-K. We also do not currently have any off-balance sheet arrangements.

21

Common Stock Repurchases

We did not repurchase any shares during the third quarter of Fiscal 2024 and repurchased 1,261,295 shares during the first nine months of Fiscal 2024 at a cost of $32.0 million, or $25.39 per share. We have $52.1 million remaining as of October 28, 2023 under our expanded share repurchase authorization announced in June 2023. We repurchased 451,343 shares during the third quarter of Fiscal 2023 at a cost of $20.8 million, or $46.01 per share, and repurchased 1,380,272 shares during the first nine months of Fiscal 2023 at a cost of $72.7 million, or $52.66 per share. We accrued $4.8 million of share repurchases in the fourth quarter of Fiscal 2022 due to timing of the cash settlement which is included on the Condensed Consolidated Statements of Cash Flows for the nine months ended October 29, 2022. During the third quarter of Fiscal 2024, through December 6, 2023, we have not repurchased any shares.

Environmental and Other Contingencies

We are subject to certain loss contingencies related to environmental proceedings and other legal matters, including those disclosed in Item 1, Note 7, "Legal Proceedings", to our Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q.

New Accounting Pronouncements

Descriptions of recently issued accounting pronouncements, if any, and the accounting pronouncements adopted by us during the third quarter of Fiscal 2024 are included in Note 1 to our Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

We incorporate by reference the information regarding market risk appearing in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” under the heading “Financial Market Risk” in our Annual Report on Form 10-K for the fiscal year ended January 28, 2023. There have been no material changes to our exposure to market risks from those disclosed in the Form 10-K.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

We have established disclosure controls and procedures designed to ensure that information required to be disclosed by us, including our consolidated subsidiaries, in the reports we file or submit under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), is made known to the officers who certify our financial reports and to other members of senior management. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving desired objectives.

Based on their evaluation as of October 28, 2023, the principal executive officer and principal financial officer of the Company have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Exchange Act) were effective to ensure that the information required to be disclosed by us in the reports that we file or submit under the Exchange Act is (i) recorded, processed, summarized and reported within time periods specified in SEC rules and forms and (ii) accumulated and communicated to our management, including our principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

During the third quarter of Fiscal 2024, we implemented a new inventory management system for our wholesale operations and we updated and modified internal controls over financial reporting related to wholesale inventory. There were no other changes in our internal control over financial reporting that occurred during our third quarter of Fiscal 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

22

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

We incorporate by reference the information regarding legal proceedings in Item 1, Note 7, “Legal Proceedings”, to our Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q.

Item 1A. Risk Factors

You should carefully consider the risk factors discussed in Part I, “Item 1A. Risk Factors” in the Annual Report on Form 10-K for the fiscal year ended January 28, 2023, which could materially affect our business, financial condition or future results. The risks described in this report, and in our Annual Report are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Repurchases (shown in thousands except share and per share amounts):

ISSUER PURCHASES OF EQUITY SECURITIES
Period	(a) Total Number of Shares Purchased		(b) Average Price Paid per Share		(c) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs		(d) Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plans or Programs
August 2023
7-30-23 to 8-26-23(1)		—	$	—		—	$	52,109
September 2023
8-27-23 to 9-23-23(1)		—	$	—		—	$	52,109
October 2023
9-24-23 to 10-28-23 (1)		—	$	—		—	$	52,109
9-24-23 to 10-28-23 (2)		1,518	$	28.71		—		—
Total		1,518	$	28.71		—	$	52,109
(1) Share repurchases were made pursuant to a $100.0 million share repurchase program approved by the Board of Directors and announced in February 2022. In June 2023, the Board of Directors approved an additional $50.0 million for share repurchases. We expect to implement the balance of the repurchase program through purchases made from time to time either in the open market or through private transactions, in accordance with the regulations of the SEC and other applicable legal requirements.
(2) These shares represent shares withheld from vested restricted stock to satisfy the minimum withholding requirement for federal and state taxes.

Item 5. Other Information

(c) During the third quarter of Fiscal 2024, no director or Section 16 officer of the Company adopted or terminated any Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading arrangements (in each case, as defined in Item 408 (a) of Regulation S-K).

23

Item 6. Exhibits

Exhibit Index
(31.1)	Certification of the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
(31.2)	Certification of the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
(32.1)	Certification of the Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
(32.2)	Certification of the Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	Inline XBRL Instance Document (The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.)
101.SCH	Inline XBRL Taxonomy Extension Schema Document
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

24

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Genesco Inc.
By:	/s/ Thomas A. George
	Thomas A. George
	Senior Vice President - Finance and Chief Financial Officer

Date: December 7, 2023

25

EX-31.1

Exhibit 31.1

CERTIFICATIONS

I, Mimi E. Vaughn, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Genesco Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: December 7, 2023

/s/ Mimi E. Vaughn

Mimi E. Vaughn

Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATIONS

I, Thomas A. George, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Genesco Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: December 7, 2023

/s/ Thomas A. George

Thomas A. George

Senior Vice President - Finance and Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Genesco Inc. (the “Company”) on Form 10-Q for the period ending October 28, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Mimi E. Vaughn, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Mimi E. Vaughn

Mimi E. Vaughn

Chief Executive Officer

December 7, 2023

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Genesco Inc. (the “Company”) on Form 10-Q for the period ending October 28, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Thomas A. George, Senior Vice President - Finance and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Thomas A. George

Thomas A. George

Senior Vice President - Finance and Chief Financial Officer

December 7, 2023

XML

Cover Page - shares	9 Months Ended
	Oct. 28, 2023	Nov. 24, 2023
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 28, 2023
Document Transition Report	false
Entity File Number	1-3083
Entity Registrant Name	Genesco Inc
Entity Incorporation, State or Country Code	TN
Entity Tax Identification Number	62-0211340
Entity Address, Address Line One	535 Marriott Drive
Entity Address, City or Town	Nashville
Entity Address, State or Province	TN
Entity Address, Postal Zip Code	37214
City Area Code	615
Local Phone Number	367-7000
Title of 12(b) Security	Common Stock, $1.00 par value
Trading Symbol	GCO
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock Shares Outstanding		11,489,017
Entity Central Index Key	0000018498
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--02-03

XML

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Oct. 28, 2023		Jan. 28, 2023	Oct. 29, 2022
Current Assets:
Cash and cash equivalents	$ 21,691		$ 47,990	$ 32,113
Accounts receivable, net of allowances of $4,836 at October 28, 2023, $3,710 at January 28, 2023 and $5,910 at October 29, 2022	56,934		40,818	48,670
Inventories	516,735		458,017	563,490
Prepaids and other current assets	43,350		25,844	37,575
Total current assets	638,710		572,669	681,848
Property and equipment, net	245,009		233,733	221,207
Operating lease right of use assets	459,524		470,991	483,403
Non-current prepaid income taxes	55,632		54,111	52,319
Goodwill	9,283		38,123	37,903
Other intangibles	26,442		27,430	26,208
Deferred income taxes	33,163		28,563	12,168
Other noncurrent assets	25,168		30,806	21,937
Total Assets	1,492,931	[1]	1,456,426	1,536,993	[2]
Current Liabilities:
Accounts payable	186,683		144,998	223,404
Current portion - long-term debt	0		0	3,484
Current portion - operating lease liabilities	134,850		134,458	136,294
Other accrued liabilities	75,631		81,327	82,193
Total current liabilities	397,164		360,783	445,375
Long-term debt	128,163		44,858	85,904
Long-term operating lease liabilities	387,347		401,113	413,096
Other long-term liabilities	43,299		42,706	33,275
Total liabilities	955,973		849,460	977,650
Commitments and contingent liabilities
Equity
Non-redeemable preferred stock	812		815	817
Common equity:
Common stock, $1 par value: Authorized; 80,000,000 shares Issued common stock	11,991		13,089	13,101
Additional paid-in capital	316,206		305,260	301,692
Retained earnings	269,576		346,870	307,921
Accumulated other comprehensive loss	(43,770)		(41,211)	(46,331)
Treasury shares, at cost (488,464 shares)	(17,857)		(17,857)	(17,857)
Total equity	536,958		606,966	559,343
Total Liabilities and Equity	$ 1,492,931		$ 1,456,426	$ 1,536,993

[1] Of our $704.5 million of long-lived assets, $87.9 million and $12.9 million relate to long-lived assets in the U.K. and Canada, respectively.

[2] (2) Of our $704.6 million of long-lived assets, $89.3 million and $18.5 million relate to long-lived assets in the U.K. and Canada, respectively.

XML

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Oct. 28, 2023	Jan. 28, 2023	Oct. 29, 2022
Current Assets:
Allowances on accounts receivable	$ 4,836	$ 3,710	$ 5,910
Common equity:
Common stock, par value (in dollars per share)	$ 1	$ 1	$ 1
Common stock, shares authorized (in shares)	80,000,000	80,000,000	80,000,000
Treasury Stock, Shares	488,464	488,464	488,464

XML

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended				9 Months Ended
	Oct. 28, 2023		Oct. 29, 2022		Oct. 28, 2023		Oct. 29, 2022
Income Statement [Abstract]
Net sales	$ 579,315	[1]	$ 603,788	[2]	$ 1,585,674	[3]	$ 1,659,868	[4]
Cost of sales	300,890		309,981		828,921		860,303
Gross margin	278,425		293,807		756,753		799,565
Selling and administrative expenses	267,474		267,734		778,491		756,318
Goodwill impairment	0		0		28,453	[5]	0
Asset impairments and other, net	99	[6]	0		581	[7]	(154)	[8]
Operating income (loss)	10,852		26,073		(50,772)		43,401
Other components of net periodic benefit cost	148		50		388		198
Interest expense, net	2,207		906		6,241		1,608
Earnings (loss) from continuing operations before income taxes	8,497		25,117		(57,401)		41,595
Income tax expense (benefit)	1,908		4,693		(13,483)		8,551
Earnings (loss) from continuing operations	6,589		20,424		(43,918)		33,044
Loss from discontinued operations, net of tax	(50)		(48)		(98)		(78)
Net Earnings (Loss)	$ 6,539		$ 20,376		$ (44,016)		$ 32,966
Basic earnings (loss) per common share:
Continuing operations (in dollars per share)	$ 0.6		$ 1.68		$ (3.87)		$ 2.61
Discontinued operations (in dollars per share)	0		0		(0.01)		0
Net earnings (loss) (in dollars per share)	0.6		1.68		(3.88)		2.61
Diluted earnings (loss) per common share:
Continuing operations (in dollars per share)	0.6		1.66		(3.87)		2.56
Discontinued operations (in dollars per share)	0		(0.01)		(0.01)		0
Net earnings (loss) (in dollars per share)	$ 0.6		$ 1.65		$ (3.88)		$ 2.56
Weighted average shares outstanding:
Basic (in shares)	10,898		12,138		11,353		12,637
Diluted (in shares)	10,972		12,326		11,353		12,901

[1] Net sales in North America and in the U.K., which includes the ROI, accounted for 80% and 20%, respectively, of our net sales in the third quarter of Fiscal 2024.

[2] Net sales in North America and in the U.K., which includes the ROI, accounted for 83% and 17%, respectively, of our net sales for the third quarter of Fiscal 2023.

[3] (1) Net sales in North America and in the U.K., which includes the ROI, accounted for 79% and 21%, respectively, of our net sales in the first nine months of Fiscal 2024.

[4] (1) Net sales in North America and in the U.K., which includes the ROI, accounted for 82% and 18%, respectively, of our net sales for the first nine months of Fiscal 2023.

[5] (2) Goodwill impairment of $28.5 million is related to Genesco Brands Group.

[6] Asset impairments and other includes a $0.1 million charge for asset impairments in Journeys Group.

[7] (3) Asset impairments and other includes a $0.6 million charge for asset impairments in Journeys Group.

[8] (2) Asset impairments and other includes a $0.5 million charge for asset impairments, which includes $0.2 million in Journeys Group, $0.2 million in Schuh Group and $0.1 million in Genesco Brands Group, partially offset by a $0.7 million gain on the termination of the pension plan.

XML

Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 28, 2023	Oct. 29, 2022	Oct. 28, 2023	Oct. 29, 2022
Statement of Comprehensive Income [Abstract]
Net earnings (loss)	$ 6,539	$ 20,376	$ (44,016)	$ 32,966
Other comprehensive income (loss):
Postretirement liability adjustments, net of tax	62	13	153	76
Foreign currency translation adjustments	(5,800)	(4,420)	(2,712)	(9,999)
Total other comprehensive loss	(5,738)	(4,407)	(2,559)	(9,923)
Comprehensive Income (Loss)	$ 801	$ 15,969	$ (46,575)	$ 23,043

XML

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Oct. 28, 2023		Oct. 29, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net earnings (loss)	$ (44,016)		$ 32,966
Adjustments to reconcile net earnings (loss) to net cash used in operating activities:
Depreciation and amortization	35,449		31,901
Deferred income taxes	(3,929)		(10,728)
Goodwill impairment	28,453	[1]	0
Impairment of long-lived assets	581		542
Share-based compensation expense	11,107		10,464
Other	1,225		999
Changes in working capital and other assets and liabilities:
Accounts receivable	(16,958)		(10,224)
Inventories	(61,086)		(293,904)
Prepaids and other current assets	(17,718)		33,133
Accounts payable	44,551		70,312
Other accrued liabilities	(3,454)		(45,194)
Other assets and liabilities	2,255		(64,237)
Net cash used in operating activities	(23,540)		(243,970)
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(49,738)		(39,845)
Proceeds from asset sales	87		0
Net cash used in investing activities	(49,651)		(39,845)
CASH FLOWS FROM FINANCING ACTIVITIES:
Borrowings under revolving credit facility	365,416		212,086
Payments on revolving credit facility	(282,083)		(136,375)
Shares repurchased related to share repurchase plan	(32,027)		(77,470)
Shares repurchased related to taxes for share-based awards	(2,249)		(3,942)
Change in overdraft balances	(1,847)		4,052
Other	(12)		2
Net cash provided by (used in) financing activities	47,198		(1,647)
Effect of foreign exchange rate fluctuations on cash	(306)		(2,950)
Net decrease in cash and cash equivalents	(26,299)		(288,412)
Cash and cash equivalents at beginning of period	47,990		320,525
Cash and cash equivalents at end of period	21,691		32,113
Supplemental information:
Interest paid	5,711		1,276
Income taxes paid	5,487		33,941
Cash paid for amounts included in measurement of operating lease liabilities	130,468		135,116
Operating lease assets obtained in exchange for new operating lease liabilities	$ 111,105		$ 71,598

[1] (2) Goodwill impairment of $28.5 million is related to Genesco Brands Group.

XML

Condensed Consolidated Statements of Equity - USD ($) $ in Thousands	Total	Non-Redeemable Preferred Stock	Common Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Loss	Treasury Shares
Beginning balance at Jan. 29, 2022	$ 602,468	$ 827	$ 14,256	$ 291,444	$ 350,206	$ (36,408)	$ (17,857)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings (loss)	4,947				4,947
Other comprehensive income (loss)	(3,817)					(3,817)
Share-based compensation expense	3,239			3,239
Restricted stock issuance			78	(78)
Shares repurchased	(6,500)		(104)		(6,396)
Other	1	(9)	(13)	23
Ending balance at Apr. 30, 2022	600,338	818	14,217	294,628	348,757	(40,225)	(17,857)
Beginning balance at Jan. 29, 2022	602,468	827	14,256	291,444	350,206	(36,408)	(17,857)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings (loss)	32,966
Other comprehensive income (loss)	(9,923)
Shares repurchased	(72,700)
Ending balance at Oct. 29, 2022	559,343	817	13,101	301,692	307,921	(46,331)	(17,857)
Beginning balance at Apr. 30, 2022	600,338	818	14,217	294,628	348,757	(40,225)	(17,857)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings (loss)	7,643				7,643
Other comprehensive income (loss)	(1,699)					(1,699)
Share-based compensation expense	3,549			3,549
Restricted stock issuance			239	(239)
Restricted shares withheld for taxes	(3,875)		(72)	72	(3,875)
Shares repurchased	(45,422)		(826)		(44,596)
Other	(1)		(1)
Ending balance at Jul. 30, 2022	560,533	818	13,557	298,010	307,929	(41,924)	(17,857)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings (loss)	20,376				20,376
Other comprehensive income (loss)	(4,407)					(4,407)
Share-based compensation expense	3,676			3,676
Restricted shares withheld for taxes	(67)		(2)	2	(67)
Shares repurchased	(20,768)		(451)		(20,317)
Other		(1)	(3)	4
Ending balance at Oct. 29, 2022	559,343	817	13,101	301,692	307,921	(46,331)	(17,857)
Beginning balance at Jan. 28, 2023	606,966	815	13,089	305,260	346,870	(41,211)	(17,857)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings (loss)	(18,890)				(18,890)
Other comprehensive income (loss)	474					474
Share-based compensation expense	3,772			3,772
Restricted stock issuance			234	(234)
Restricted shares withheld for taxes	(449)		(13)	13	(449)
Shares repurchased	(9,170)		(255)		(8,915)
Other	(78)	(3)	(3)	6	(78)
Ending balance at Apr. 29, 2023	582,625	812	13,052	308,817	318,538	(40,737)	(17,857)
Beginning balance at Jan. 28, 2023	606,966	815	13,089	305,260	346,870	(41,211)	(17,857)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings (loss)	(44,016)
Other comprehensive income (loss)	(2,559)
Shares repurchased	(32,000)
Ending balance at Oct. 28, 2023	536,958	812	11,991	316,206	269,576	(43,770)	(17,857)
Beginning balance at Apr. 29, 2023	582,625	812	13,052	308,817	318,538	(40,737)	(17,857)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings (loss)	(31,665)				(31,665)
Other comprehensive income (loss)	2,705					2,705
Share-based compensation expense	4,153			4,153
Restricted stock issuance			40	(40)
Restricted shares withheld for taxes	(1,756)		(72)	72	(1,756)
Shares repurchased	(22,857)		(1,006)		(21,851)
Other	(186)		(18)	17	(185)
Ending balance at Jul. 29, 2023	533,019	812	11,996	313,019	263,081	(38,032)	(17,857)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings (loss)	6,539				6,539
Other comprehensive income (loss)	(5,738)					(5,738)
Share-based compensation expense	3,182			3,182
Restricted shares withheld for taxes	(44)		(1)	1	(44)
Other			(4)	4
Ending balance at Oct. 28, 2023	$ 536,958	$ 812	$ 11,991	$ 316,206	$ 269,576	$ (43,770)	$ (17,857)

XML

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Oct. 28, 2023	Jul. 29, 2023	Apr. 29, 2023	Oct. 29, 2022	Jul. 30, 2022	Apr. 30, 2022	Oct. 28, 2023	Oct. 29, 2022
Pay vs Performance Disclosure
Net Income (Loss)	$ 6,539	$ (31,665)	$ (18,890)	$ 20,376	$ 7,643	$ 4,947	$ (44,016)	$ 32,966

XML

Insider Trading Arrangements	9 Months Ended
	Oct. 28, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

XML

Summary of Significant Accounting Policies

9 Months Ended

Oct. 28, 2023

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Note 1

Summary of Significant Accounting Policies

Basis of Presentation

These Condensed Consolidated Financial Statements should be read in conjunction with our Consolidated Financial Statements and Notes for Fiscal 2023, which are contained in our Annual Report on Form 10-K as filed with the SEC on March 22, 2023. The Condensed Consolidated Financial Statements and Notes contained in this report are unaudited but reflect all adjustments, including normal recurring adjustments, necessary for a fair presentation of the results for the interim periods of the fiscal year ending February 3, 2024 ("Fiscal 2024"), which is a 53-week year, and of the fiscal year ended January 28, 2023 ("Fiscal 2023"). All subsidiaries are consolidated in the Condensed Consolidated Financial Statements. All significant intercompany transactions and accounts have been eliminated. The results of operations for any interim period are not necessarily indicative of results for the full year. The Condensed Consolidated Financial Statements and the related Notes have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and notes required by U.S. Generally Accepted Accounting Principles (“GAAP”) for complete financial statements. The Condensed Consolidated Balance Sheet as of January 28, 2023 has been derived from the audited financial statements at that date.

Nature of Operations

Genesco Inc. and its subsidiaries (collectively the "Company", "Genesco," "we", "our", or "us") business includes the sourcing and design, marketing and distribution of footwear and accessories through retail stores in the U.S., Puerto Rico and Canada primarily under the Journeys®, Journeys Kidz®, Little Burgundy® and Johnston & Murphy® banners and under the Schuh® banner in the United Kingdom (“U.K.”) and the Republic of Ireland (“ROI”); through e-commerce websites including the following: journeys.com, journeyskidz.com, journeys.ca, littleburgundyshoes.com, schuh.co.uk, schuh.ie, schuh.eu, johnstonmurphy.com, johnstonmurphy.ca, nashvilleshoewarehouse.com and dockersshoes.com as well as catalogs. We also source, design, market and distribute footwear and accessories at wholesale, primarily under our Johnston & Murphy brand, the licensed Levi's® brand, the licensed Dockers® brand, the licensed G.H. Bass® brand and other brands that we license for footwear. At October 28, 2023, we operated 1,360 retail stores in the U.S., Puerto Rico, Canada, the U.K. and the ROI.

During the three and nine months ended October 28, 2023 and October 29, 2022, we operated four reportable business segments (not including corporate): (i) Journeys Group, comprised of the Journeys, Journeys Kidz and Little Burgundy retail footwear chains and e-commerce operations; (ii) Schuh Group, comprised of the Schuh retail footwear chain and e-commerce operations; (iii) Johnston & Murphy Group, comprised of Johnston & Murphy retail operations, e-commerce operations and wholesale distribution of products under the Johnston & Murphy brand; and (iv) Genesco Brands Group, comprised of the licensed Dockers, Levi's, and G.H. Bass brands, as well as other brands we license for footwear.

Selling and Administrative Expenses

Wholesale costs of distribution are included in selling and administrative expenses on the Condensed Consolidated Statements of Operations in the amount of $3.1 million and $3.7 million for the third quarters of Fiscal 2024 and Fiscal 2023, respectively, and $9.1 million and $9.5 million for the first nine months of Fiscal 2024 and Fiscal 2023, respectively.

Retail occupancy costs recorded in selling and administrative expenses were $75.5 million and $77.5 million for the third quarters of Fiscal 2024 and Fiscal 2023, respectively, and $228.3 million and $231.8 million for the first nine months of Fiscal 2024 and Fiscal 2023, respectively.

Advertising Costs

Advertising costs were $33.6 million and $31.3 million for the third quarters of Fiscal 2024 and Fiscal 2023, respectively, and $85.3 million and $81.4 million for the first nine months of Fiscal 2024 and Fiscal 2023, respectively.

Vendor Allowances

Vendor reimbursements of cooperative advertising costs recognized as a reduction of selling and administrative expenses were $2.5 million and $5.0 million for the third quarters of Fiscal 2024 and Fiscal 2023, respectively, and $9.1 million and $11.7 million for the first nine months of Fiscal 2024 and Fiscal 2023, respectively. During the first nine months of each of Fiscal 2024 and Fiscal 2023, our cooperative advertising reimbursements received were not in excess of the costs incurred.

Note 1

Summary of Significant Accounting Policies, Continued

New Accounting Pronouncements

In November 2023, the Financial Accounting Standards Board ("FASB") issued ASU No. 2023-07, "Segment Reporting (Topic 280)". This update provides, among other things, enhanced segment disclosure requirements including disclosures about significant segment expenses. ASU No. 2023-07 is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. We plan to adopt ASU No. 2023-07 on the effective date and do not expect the adoption to have a material impact on our Consolidated Financial Statements.

We continuously monitor and review all current accounting pronouncements and standards from the FASB of U.S. GAAP for applicability to our operations and financial reporting. As of October 28, 2023, there were no other new pronouncements or interpretations that had or were expected to have a significant impact on our financial reporting.

XML

Goodwill and Other Intangible Assets

9 Months Ended

Oct. 28, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Other Intangible Assets

Note 2

Goodwill and Other Intangible Assets

The changes in the carrying amount of goodwill by segment were as follows:

(In thousands)	Journeys Group			Genesco Brands Group			Total Goodwill
Balance, January 28, 2023	$	9,662		$	28,461		$	38,123
Impairment		—			(28,453	)		(28,453	)
Effect of foreign currency exchange rates		(379	)		(8	)		(387	)
Balance, October 28, 2023	$	9,283		$	—		$	9,283

Goodwill Valuation (Genesco Brands Group)

Due to an ongoing dispute with a Genesco Brands Group licensor regarding renewal of their current license in the normal course which has not yet been resolved and based on the requirements of ASC 350, “Intangibles - Goodwill and Other,” we identified indicators of impairment in the second quarter of Fiscal 2024. When indicators of impairment are present on an interim basis, we must assess whether it is "more likely than not" (i.e., a greater than 50% chance) that an impairment has occurred. Due to the identified indicators of impairment in the second quarter of Fiscal 2024, we determined that it was "more likely than not" that an impairment had occurred and performed a full valuation of our Togast reporting unit. Consistent with our annual valuation, our analyses included preparing an income approach and a market approach model. These updated models utilize financial forecasts which exclude cash flows for the disputed license beyond completion of the current contract term. Based upon the results of these analyses, we concluded the goodwill attributed to Togast was fully impaired. As a result, the Company recorded a non-cash impairment charge of $28.5 million in the second quarter of Fiscal 2024.

Other intangibles by major classes were as follows:

	Trademarks				Customer Lists						Other						Total
(In thousands)	Oct. 28, 2023		Jan. 28, 2023		Oct. 28, 2023			Jan. 28, 2023			Oct. 28, 2023			Jan. 28, 2023			Oct. 28, 2023			Jan. 28, 2023
Gross other intangibles	$	23,514	$	24,077	$	6,445		$	6,475		$	400		$	400		$	30,359		$	30,952
Accumulated amortization		—		—		(3,517	)		(3,122	)		(400	)		(400	)		(3,917	)		(3,522	)
Net Other Intangibles	$	23,514	$	24,077	$	2,928		$	3,353		$	—		$	—		$	26,442		$	27,430

XML

Inventories

9 Months Ended

Oct. 28, 2023

Inventory Disclosure [Abstract]

Inventories

Note 3

Inventories

Inventories

(In thousands)	October 28, 2023		January 28, 2023
Wholesale finished goods	$	61,571	$	84,209
Retail merchandise		455,164		373,808
Total Inventories	$	516,735	$	458,017

XML

Fair Value

9 Months Ended

Oct. 28, 2023

Fair Value Disclosures [Abstract]

Fair Value

Note 4

Fair Value

Fair Value of Financial Instruments

The carrying amounts and fair values of our financial instruments at October 28, 2023 and January 28, 2023 are as follows:

Fair Values
(In thousands)	October 28, 2023				January 28, 2023
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
U.S. Revolver Borrowings	$	122,101	$	122,465	$	30,000	$	30,219
U.K. Revolver Borrowings		6,062		6,064		14,858		14,864
Total Long-Term Debt	$	128,163	$	128,529	$	44,858	$	45,083

Debt fair values were determined using a discounted cash flow analysis based on current market interest rates for similar types of financial instruments and would be classified in Level 2 within the fair value hierarchy.

As of October 28, 2023, we have $0.8 million of long-lived assets held and used which were measured using Level 3 inputs within the fair value hierarchy. As of October 28, 2023, we have $5.8 million of investments held and used which were measured using Level 1 inputs within the fair value hierarchy.

XML

Earnings Per Share

9 Months Ended

Oct. 28, 2023

Earnings Per Share [Abstract]

Earnings Per Share

Note 5

Earnings Per Share

Weighted-average number of shares used to calculate earnings per share are as follows:

	Three Months Ended				Nine Months Ended
(Shares in thousands)	October 28, 2023		October 29, 2022		October 28, 2023		October 29, 2022
Weighted-average number of shares - basic		10,898		12,138		11,353		12,637
Common stock equivalents		74		188		-		264
Weighted-average number of shares - diluted		10,972		12,326		11,353		12,901

Common stock equivalents of 120,000 shares are excluded for the nine months ended October 28, 2023 due to the loss from continuing operations because to do so would be anti-dilutive.

We did not repurchase any shares during the third quarter of Fiscal 2024. We repurchased 1,261,295 shares during the first nine months of Fiscal 2024 at a cost of $32.0 million, or $25.39 per share. We have $52.1 million remaining as of October 28, 2023 under our expanded share repurchase authorization announced in June 2023. We repurchased 451,343 shares during the third quarter of Fiscal 2023 at a cost of $20.8 million, or $46.01 per share, and repurchased 1,380,272 shares during the first nine months of Fiscal 2023 at a cost of $72.7 million, or $52.66 per share. We accrued $4.8 million of share repurchases in the fourth quarter of Fiscal 2022 due to timing of the cash settlement which is included on the

Note 5

Earnings Per Share, Continued

Condensed Consolidated Statements of Cash Flows for the nine months ended October 29, 2022. During the fourth quarter of Fiscal 2024, through December 6, 2023, we have not repurchased any shares.

XML

Long-Term Debt

9 Months Ended

Oct. 28, 2023

Debt Disclosure [Abstract]

Long-Term Debt

Note 6

Long-Term Debt

(In thousands)	October 28, 2023		January 28, 2023
U.S. revolver borrowings	$	122,101	$	30,000
U.K. revolver borrowings		6,062		14,858
Total long-term debt		128,163		44,858
Current portion		—		—
Total Noncurrent Portion of Long-Term Debt	$	128,163	$	44,858

The revolver borrowings outstanding under the Credit Facility as of October 28, 2023 included $117.2 million U.S. revolver borrowings and $4.9 million (C$6.8 million) related to GCO Canada ULC. In addition, revolver borrowings outstanding under the Facility Agreement were $6.1 million (£5.0 million). We were in compliance with all the relevant terms and conditions of the Credit Facility and Facility Agreement as of October 28, 2023. Excess availability under the Credit Facility was $203.4 million at October 28, 2023.

XML

Legal Proceedings

9 Months Ended

Oct. 28, 2023

Commitments and Contingencies Disclosure [Abstract]

Legal Proceedings

Note 7

Legal Proceedings

Environmental Matters

The Company has legacy obligations including environmental monitoring and reporting costs related to: (i) a 2016 Consent Judgment entered into with the United States Environmental Protection Agency involving the site of a knitting mill operated by a former subsidiary from 1965 to 1969 in Garden City, New York; and (ii) a 2010 Consent Decree with the Michigan Department of Natural Resources and Environment relating to our former Volunteer Leather Company facility in Whitehall, Michigan. We do not expect that future obligations related to either of these sites will have a material effect on our consolidated financial condition or results of operations.

Accrual for Environmental Contingencies

Related to all outstanding environmental contingencies, we had accrued $1.6 million as of October 28, 2023, $1.7 million as of January 28, 2023 and $1.4 million as of October 29, 2022. All such provisions reflect our estimates of the most likely cost (undiscounted, including both current and noncurrent portions) of resolving the contingencies, based on facts and circumstances as of the time they were made. There is no assurance that relevant facts and circumstances will not change, necessitating future changes to the provisions. Such contingent liabilities are included in the liability arising from provision for discontinued operations on the accompanying Condensed Consolidated Balance Sheets because they relate to former facilities operated by us. We have made pretax accruals for certain of these contingencies which were not material for the third quarter of Fiscal 2024 or Fiscal 2023. These charges are included in loss from discontinued operations, net in the Condensed Consolidated Statements of Operations and represent changes in estimates.

In addition to the matters specifically described in this Note, we are a party to other legal and regulatory proceedings and claims arising in the ordinary course of our business. While management does not believe that our liability with respect to any of these other matters is likely to have a material effect on our condensed consolidated financial statements, legal proceedings are subject to inherent uncertainties, and unfavorable rulings could have a material adverse impact on our condensed consolidated financial statements.

XML

Commitments

9 Months Ended

Oct. 28, 2023

Commitments and Contingencies Disclosure [Abstract]

Commitments

Note 8

Commitments

As part of our Genesco Brands Group business, we have a commitment to Samsung C&T America, Inc. (“Samsung”) related to the ultimate sale and valuation of inventories owned by Samsung. If product is sold below Samsung’s cost, we are required to pay to Samsung the difference between the sales price and its cost. At October 28, 2023, the inventory owned by Samsung had a historical cost of $14.4 million. As of October 28, 2023, we believe that we have appropriately accounted for any differences between the fair value of the Samsung inventory and Samsung's historical cost.

XML

Business Segment Information

9 Months Ended

Oct. 28, 2023

Segment Reporting [Abstract]

Business Segment Information

Note 9

Business Segment Information

Three Months Ended October 28, 2023
(In thousands)	Journeys Group		Schuh Group		Johnston & Murphy Group			Genesco Brands Group			Corporate & Other			Consolidated
Sales	$	349,367	$	118,129	$	81,414		$	32,907		$	—		$	581,817
Intercompany sales		—		—		(3	)		(2,499	)		—			(2,502	)
Net sales to external customers(1)		349,367		118,129		81,411			30,408			—			579,315
Segment operating income (loss)		11,975		5,484		2,706			(1,560	)		(7,654	)		10,951
Asset impairments and other(2)		—		—		—			—			99			99
Operating income (loss)		11,975		5,484		2,706			(1,560	)		(7,753	)		10,852
Other components of net periodic benefit cost		—		—		—			—			148			148
Interest expense, net		—		—		—			—			2,207			2,207
Earnings (loss) from continuing operations before income taxes	$	11,975	$	5,484	$	2,706		$	(1,560	)	$	(10,108	)	$	8,497
Total assets (3)	$	798,968	$	213,036	$	185,179		$	52,170		$	243,578		$	1,492,931
Depreciation and amortization		8,078		1,566		1,365			265			1,056			12,330
Capital expenditures		8,235		3,380		1,975			710			140			14,440

(1) Net sales in North America and in the U.K., which includes the ROI, accounted for 80% and 20%, respectively, of our net sales in the third quarter of Fiscal 2024.

(2) Asset impairments and other includes a $0.1 million charge for asset impairments in Journeys Group.

(3) Of our $704.5 million of long-lived assets, $87.9 million and $12.9 million relate to long-lived assets in the U.K. and Canada, respectively.

Three Months Ended October 29, 2022
(In thousands)	Journeys Group		Schuh Group		Johnston & Murphy Group		Genesco Brands Group			Corporate & Other			Consolidated
Sales	$	380,619	$	104,809	$	79,614	$	40,661		$	—		$	605,703
Intercompany sales		—		—		—		(1,915	)		—			(1,915	)
Net sales to external customers(1)		380,619		104,809		79,614		38,746			—			603,788
Operating income (loss)		27,083		5,912		3,494		(1,927	)		(8,489	)		26,073
Other components of net periodic benefit cost		—		—		—		—			50			50
Interest expense, net		—		—		—		—			906			906
Earnings (loss) from continuing operations before income taxes	$	27,083	$	5,912	$	3,494	$	(1,927	)	$	(9,445	)	$	25,117
Total assets (2)	$	841,021	$	206,996	$	193,039	$	72,586		$	223,351		$	1,536,993
Depreciation and amortization		6,849		1,485		1,092		214			1,032			10,672
Capital expenditures		4,638		2,405		1,719		370			1,708			10,840

(1) Net sales in North America and in the U.K., which includes the ROI, accounted for 83% and 17%, respectively, of our net sales for the third quarter of Fiscal 2023.

(2) Of our $704.6 million of long-lived assets, $89.3 million and $18.5 million relate to long-lived assets in the U.K. and Canada, respectively.

Note 9

Business Segment Information, Continued

Nine Months Ended October 28, 2023
(In thousands)	Journeys Group			Schuh Group		Johnston & Murphy Group			Genesco Brands Group			Corporate & Other			Consolidated
Sales	$	908,832		$	334,033	$	241,832		$	104,232		$	—		$	1,588,929
Intercompany sales		—			—		(9	)		(3,246	)		—			(3,255	)
Net sales to external customers(1)		908,832			334,033		241,823			100,986			—			1,585,674
Segment operating income (loss)		(21,265	)		12,110		10,178			259			(23,020	)		(21,738	)
Goodwill impairment(2)		-			-		-			-			28,453			28,453
Asset impairments and other(3)		—			—		—			—			581			581
Operating income (loss)		(21,265	)		12,110		10,178			259			(52,054	)		(50,772	)
Other components of net periodic benefit cost		—			—		—			—			388			388
Interest expense, net		—			—		—			—			6,241			6,241
Earnings (loss) from continuing    operations before income taxes	$	(21,265	)	$	12,110	$	10,178		$	259		$	(58,683	)	$	(57,401	)
Depreciation and amortization	$	23,235		$	4,751	$	3,622		$	669		$	3,172		$	35,449
Capital expenditures		32,447			9,376		5,277			1,788			850			49,738

(1) Net sales in North America and in the U.K., which includes the ROI, accounted for 79% and 21%, respectively, of our net sales in the first nine months of Fiscal 2024.

(2) Goodwill impairment of $28.5 million is related to Genesco Brands Group.

(3) Asset impairments and other includes a $0.6 million charge for asset impairments in Journeys Group.

Nine Months Ended October 29, 2022
(In thousands)	Journeys Group		Schuh Group		Johnston & Murphy Group		Genesco Brands Group			Corporate & Other			Consolidated
Sales	$	1,016,396	$	294,486	$	225,448	$	126,442		$	—		$	1,662,772
Intercompany sales		—		—		—		(2,904	)		—			(2,904	)
Net sales to external customers(1)		1,016,396		294,486		225,448		123,538			—		$	1,659,868
Segment operating income (loss)		51,235		5,260		7,256		2,551			(23,055	)	$	43,247
Asset impairments and other(2)		—		—		—		—			(154	)		(154	)
Operating income (loss)		51,235		5,260		7,256		2,551			(22,901	)		43,401
Other components of net periodic benefit cost		—		—		—		—			198			198
Interest expense		—		—		—		—			1,608			1,608
Earnings (loss) from continuing    operations before income taxes	$	51,235	$	5,260	$	7,256	$	2,551		$	(24,707	)	$	41,595
Depreciation and amortization	$	21,060	$	4,607	$	3,271	$	692		$	2,271		$	31,901
Capital expenditures		15,539		6,278		5,528		1,033			11,467			39,845

(1) Net sales in North America and in the U.K., which includes the ROI, accounted for 82% and 18%, respectively, of our net sales for the first nine months of Fiscal 2023.

(2) Asset impairments and other includes a $0.5 million charge for asset impairments, which includes $0.2 million in Journeys Group, $0.2 million in Schuh Group and $0.1 million in Genesco Brands Group, partially offset by a $0.7 million gain on the termination of the pension plan.

XML

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Oct. 28, 2023

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

These Condensed Consolidated Financial Statements should be read in conjunction with our Consolidated Financial Statements and Notes for Fiscal 2023, which are contained in our Annual Report on Form 10-K as filed with the SEC on March 22, 2023. The Condensed Consolidated Financial Statements and Notes contained in this report are unaudited but reflect all adjustments, including normal recurring adjustments, necessary for a fair presentation of the results for the interim periods of the fiscal year ending February 3, 2024 ("Fiscal 2024"), which is a 53-week year, and of the fiscal year ended January 28, 2023 ("Fiscal 2023"). All subsidiaries are consolidated in the Condensed Consolidated Financial Statements. All significant intercompany transactions and accounts have been eliminated. The results of operations for any interim period are not necessarily indicative of results for the full year. The Condensed Consolidated Financial Statements and the related Notes have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and notes required by U.S. Generally Accepted Accounting Principles (“GAAP”) for complete financial statements. The Condensed Consolidated Balance Sheet as of January 28, 2023 has been derived from the audited financial statements at that date.

Nature of Operations

Nature of Operations

Genesco Inc. and its subsidiaries (collectively the "Company", "Genesco," "we", "our", or "us") business includes the sourcing and design, marketing and distribution of footwear and accessories through retail stores in the U.S., Puerto Rico and Canada primarily under the Journeys®, Journeys Kidz®, Little Burgundy® and Johnston & Murphy® banners and under the Schuh® banner in the United Kingdom (“U.K.”) and the Republic of Ireland (“ROI”); through e-commerce websites including the following: journeys.com, journeyskidz.com, journeys.ca, littleburgundyshoes.com, schuh.co.uk, schuh.ie, schuh.eu, johnstonmurphy.com, johnstonmurphy.ca, nashvilleshoewarehouse.com and dockersshoes.com as well as catalogs. We also source, design, market and distribute footwear and accessories at wholesale, primarily under our Johnston & Murphy brand, the licensed Levi's® brand, the licensed Dockers® brand, the licensed G.H. Bass® brand and other brands that we license for footwear. At October 28, 2023, we operated 1,360 retail stores in the U.S., Puerto Rico, Canada, the U.K. and the ROI.

During the three and nine months ended October 28, 2023 and October 29, 2022, we operated four reportable business segments (not including corporate): (i) Journeys Group, comprised of the Journeys, Journeys Kidz and Little Burgundy retail footwear chains and e-commerce operations; (ii) Schuh Group, comprised of the Schuh retail footwear chain and e-commerce operations; (iii) Johnston & Murphy Group, comprised of Johnston & Murphy retail operations, e-commerce operations and wholesale distribution of products under the Johnston & Murphy brand; and (iv) Genesco Brands Group, comprised of the licensed Dockers, Levi's, and G.H. Bass brands, as well as other brands we license for footwear.

Selling and Administrative Expenses

Selling and Administrative Expenses

Wholesale costs of distribution are included in selling and administrative expenses on the Condensed Consolidated Statements of Operations in the amount of $3.1 million and $3.7 million for the third quarters of Fiscal 2024 and Fiscal 2023, respectively, and $9.1 million and $9.5 million for the first nine months of Fiscal 2024 and Fiscal 2023, respectively.

Retail occupancy costs recorded in selling and administrative expenses were $75.5 million and $77.5 million for the third quarters of Fiscal 2024 and Fiscal 2023, respectively, and $228.3 million and $231.8 million for the first nine months of Fiscal 2024 and Fiscal 2023, respectively.

Advertising Costs

Advertising Costs

Advertising costs were $33.6 million and $31.3 million for the third quarters of Fiscal 2024 and Fiscal 2023, respectively, and $85.3 million and $81.4 million for the first nine months of Fiscal 2024 and Fiscal 2023, respectively.

Vendor Allowances

Vendor Allowances

Vendor reimbursements of cooperative advertising costs recognized as a reduction of selling and administrative expenses were $2.5 million and $5.0 million for the third quarters of Fiscal 2024 and Fiscal 2023, respectively, and $9.1 million and $11.7 million for the first nine months of Fiscal 2024 and Fiscal 2023, respectively. During the first nine months of each of Fiscal 2024 and Fiscal 2023, our cooperative advertising reimbursements received were not in excess of the costs incurred.

New Accounting Pronouncements

New Accounting Pronouncements

In November 2023, the Financial Accounting Standards Board ("FASB") issued ASU No. 2023-07, "Segment Reporting (Topic 280)". This update provides, among other things, enhanced segment disclosure requirements including disclosures about significant segment expenses. ASU No. 2023-07 is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. We plan to adopt ASU No. 2023-07 on the effective date and do not expect the adoption to have a material impact on our Consolidated Financial Statements.

We continuously monitor and review all current accounting pronouncements and standards from the FASB of U.S. GAAP for applicability to our operations and financial reporting. As of October 28, 2023, there were no other new pronouncements or interpretations that had or were expected to have a significant impact on our financial reporting.

XML

Goodwill and Other Intangible Assets (Tables)

9 Months Ended

Oct. 28, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Summary of Changes in Carrying Amount of Goodwill by Segment

The changes in the carrying amount of goodwill by segment were as follows:

(In thousands)	Journeys Group			Genesco Brands Group			Total Goodwill
Balance, January 28, 2023	$	9,662		$	28,461		$	38,123
Impairment		—			(28,453	)		(28,453	)
Effect of foreign currency exchange rates		(379	)		(8	)		(387	)
Balance, October 28, 2023	$	9,283		$	—		$	9,283

Summary of Other Intangible Assets

Other intangibles by major classes were as follows:

	Trademarks				Customer Lists						Other						Total
(In thousands)	Oct. 28, 2023		Jan. 28, 2023		Oct. 28, 2023			Jan. 28, 2023			Oct. 28, 2023			Jan. 28, 2023			Oct. 28, 2023			Jan. 28, 2023
Gross other intangibles	$	23,514	$	24,077	$	6,445		$	6,475		$	400		$	400		$	30,359		$	30,952
Accumulated amortization		—		—		(3,517	)		(3,122	)		(400	)		(400	)		(3,917	)		(3,522	)
Net Other Intangibles	$	23,514	$	24,077	$	2,928		$	3,353		$	—		$	—		$	26,442		$	27,430

XML

Inventories (Tables)

9 Months Ended

Oct. 28, 2023

Inventory Disclosure [Abstract]

Schedule of Inventories

Inventories

(In thousands)	October 28, 2023		January 28, 2023
Wholesale finished goods	$	61,571	$	84,209
Retail merchandise		455,164		373,808
Total Inventories	$	516,735	$	458,017

XML

Fair Value (Tables)

9 Months Ended

Oct. 28, 2023

Fair Value Disclosures [Abstract]

Schedule of Fair Values of Financial Instruments

The carrying amounts and fair values of our financial instruments at October 28, 2023 and January 28, 2023 are as follows:

Fair Values
(In thousands)	October 28, 2023				January 28, 2023
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
U.S. Revolver Borrowings	$	122,101	$	122,465	$	30,000	$	30,219
U.K. Revolver Borrowings		6,062		6,064		14,858		14,864
Total Long-Term Debt	$	128,163	$	128,529	$	44,858	$	45,083

XML

Earnings Per Share (Tables)

9 Months Ended

Oct. 28, 2023

Earnings Per Share [Abstract]

Summary of Weighted-Average Number of Shares

Weighted-average number of shares used to calculate earnings per share are as follows:

	Three Months Ended				Nine Months Ended
(Shares in thousands)	October 28, 2023		October 29, 2022		October 28, 2023		October 29, 2022
Weighted-average number of shares - basic		10,898		12,138		11,353		12,637
Common stock equivalents		74		188		-		264
Weighted-average number of shares - diluted		10,972		12,326		11,353		12,901

XML

Long-Term Debt (Tables)

9 Months Ended

Oct. 28, 2023

Debt Disclosure [Abstract]

Schedule of Long-Term Debt

Long-Term Debt

(In thousands)	October 28, 2023		January 28, 2023
U.S. revolver borrowings	$	122,101	$	30,000
U.K. revolver borrowings		6,062		14,858
Total long-term debt		128,163		44,858
Current portion		—		—
Total Noncurrent Portion of Long-Term Debt	$	128,163	$	44,858

XML

Business Segment Information (Tables)

9 Months Ended

Oct. 28, 2023

Segment Reporting [Abstract]

Schedule of Business Segment Information

Three Months Ended October 28, 2023
(In thousands)	Journeys Group		Schuh Group		Johnston & Murphy Group			Genesco Brands Group			Corporate & Other			Consolidated
Sales	$	349,367	$	118,129	$	81,414		$	32,907		$	—		$	581,817
Intercompany sales		—		—		(3	)		(2,499	)		—			(2,502	)
Net sales to external customers(1)		349,367		118,129		81,411			30,408			—			579,315
Segment operating income (loss)		11,975		5,484		2,706			(1,560	)		(7,654	)		10,951
Asset impairments and other(2)		—		—		—			—			99			99
Operating income (loss)		11,975		5,484		2,706			(1,560	)		(7,753	)		10,852
Other components of net periodic benefit cost		—		—		—			—			148			148
Interest expense, net		—		—		—			—			2,207			2,207
Earnings (loss) from continuing operations before income taxes	$	11,975	$	5,484	$	2,706		$	(1,560	)	$	(10,108	)	$	8,497
Total assets (3)	$	798,968	$	213,036	$	185,179		$	52,170		$	243,578		$	1,492,931
Depreciation and amortization		8,078		1,566		1,365			265			1,056			12,330
Capital expenditures		8,235		3,380		1,975			710			140			14,440

(1) Net sales in North America and in the U.K., which includes the ROI, accounted for 80% and 20%, respectively, of our net sales in the third quarter of Fiscal 2024.

(2) Asset impairments and other includes a $0.1 million charge for asset impairments in Journeys Group.

(3) Of our $704.5 million of long-lived assets, $87.9 million and $12.9 million relate to long-lived assets in the U.K. and Canada, respectively.

Three Months Ended October 29, 2022
(In thousands)	Journeys Group		Schuh Group		Johnston & Murphy Group		Genesco Brands Group			Corporate & Other			Consolidated
Sales	$	380,619	$	104,809	$	79,614	$	40,661		$	—		$	605,703
Intercompany sales		—		—		—		(1,915	)		—			(1,915	)
Net sales to external customers(1)		380,619		104,809		79,614		38,746			—			603,788
Operating income (loss)		27,083		5,912		3,494		(1,927	)		(8,489	)		26,073
Other components of net periodic benefit cost		—		—		—		—			50			50
Interest expense, net		—		—		—		—			906			906
Earnings (loss) from continuing operations before income taxes	$	27,083	$	5,912	$	3,494	$	(1,927	)	$	(9,445	)	$	25,117
Total assets (2)	$	841,021	$	206,996	$	193,039	$	72,586		$	223,351		$	1,536,993
Depreciation and amortization		6,849		1,485		1,092		214			1,032			10,672
Capital expenditures		4,638		2,405		1,719		370			1,708			10,840

(1) Net sales in North America and in the U.K., which includes the ROI, accounted for 83% and 17%, respectively, of our net sales for the third quarter of Fiscal 2023.

(2) Of our $704.6 million of long-lived assets, $89.3 million and $18.5 million relate to long-lived assets in the U.K. and Canada, respectively.

Note 9

Business Segment Information, Continued

Nine Months Ended October 28, 2023
(In thousands)	Journeys Group			Schuh Group		Johnston & Murphy Group			Genesco Brands Group			Corporate & Other			Consolidated
Sales	$	908,832		$	334,033	$	241,832		$	104,232		$	—		$	1,588,929
Intercompany sales		—			—		(9	)		(3,246	)		—			(3,255	)
Net sales to external customers(1)		908,832			334,033		241,823			100,986			—			1,585,674
Segment operating income (loss)		(21,265	)		12,110		10,178			259			(23,020	)		(21,738	)
Goodwill impairment(2)		-			-		-			-			28,453			28,453
Asset impairments and other(3)		—			—		—			—			581			581
Operating income (loss)		(21,265	)		12,110		10,178			259			(52,054	)		(50,772	)
Other components of net periodic benefit cost		—			—		—			—			388			388
Interest expense, net		—			—		—			—			6,241			6,241
Earnings (loss) from continuing    operations before income taxes	$	(21,265	)	$	12,110	$	10,178		$	259		$	(58,683	)	$	(57,401	)
Depreciation and amortization	$	23,235		$	4,751	$	3,622		$	669		$	3,172		$	35,449
Capital expenditures		32,447			9,376		5,277			1,788			850			49,738

(1) Net sales in North America and in the U.K., which includes the ROI, accounted for 79% and 21%, respectively, of our net sales in the first nine months of Fiscal 2024.

(2) Goodwill impairment of $28.5 million is related to Genesco Brands Group.

(3) Asset impairments and other includes a $0.6 million charge for asset impairments in Journeys Group.

Nine Months Ended October 29, 2022
(In thousands)	Journeys Group		Schuh Group		Johnston & Murphy Group		Genesco Brands Group			Corporate & Other			Consolidated
Sales	$	1,016,396	$	294,486	$	225,448	$	126,442		$	—		$	1,662,772
Intercompany sales		—		—		—		(2,904	)		—			(2,904	)
Net sales to external customers(1)		1,016,396		294,486		225,448		123,538			—		$	1,659,868
Segment operating income (loss)		51,235		5,260		7,256		2,551			(23,055	)	$	43,247
Asset impairments and other(2)		—		—		—		—			(154	)		(154	)
Operating income (loss)		51,235		5,260		7,256		2,551			(22,901	)		43,401
Other components of net periodic benefit cost		—		—		—		—			198			198
Interest expense		—		—		—		—			1,608			1,608
Earnings (loss) from continuing    operations before income taxes	$	51,235	$	5,260	$	7,256	$	2,551		$	(24,707	)	$	41,595
Depreciation and amortization	$	21,060	$	4,607	$	3,271	$	692		$	2,271		$	31,901
Capital expenditures		15,539		6,278		5,528		1,033			11,467			39,845

(1) Net sales in North America and in the U.K., which includes the ROI, accounted for 82% and 18%, respectively, of our net sales for the first nine months of Fiscal 2023.

(2) Asset impairments and other includes a $0.5 million charge for asset impairments, which includes $0.2 million in Journeys Group, $0.2 million in Schuh Group and $0.1 million in Genesco Brands Group, partially offset by a $0.7 million gain on the termination of the pension plan.

XML

Summary of Significant Accounting Policies - Additional Information (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 28, 2023 USD ($) Segment Store	Oct. 29, 2022 USD ($) Segment	Oct. 28, 2023 USD ($) Segment Store	Oct. 29, 2022 USD ($) Segment
Summary of Accounting Policies [Line Items]
Number of retail stores operated by company | Store	1,360		1,360
Number of reportable business segments | Segment	4	4	4	4
Selling and administrative expenses	$ 267,474	$ 267,734	$ 778,491	$ 756,318
Advertising costs	33,600	31,300	85,300	81,400
Vendor reimbursements of cooperative advertising costs	2,500	5,000	9,100	11,700
Wholesale Costs of Distribution
Summary of Accounting Policies [Line Items]
Selling and administrative expenses	3,100	3,700	9,100	9,500
Retail Occupancy Costs
Summary of Accounting Policies [Line Items]
Selling and administrative expenses	$ 75,500	$ 77,500	$ 228,300	$ 231,800

XML

Goodwill and Other Intangible Assets - Summary of Changes in Carrying Amount of Goodwill by Segment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 28, 2023	Oct. 29, 2022	Oct. 28, 2023		Oct. 29, 2022
Goodwill [Roll Forward]
Goodwill, beginning balance			$ 38,123
Impairment	$ 0	$ 0	(28,453)	[1]	$ 0
Effect of foreign currency exchange rates			(387)
Goodwill, ending balance	9,283	$ 37,903	9,283		$ 37,903
Journeys Group
Goodwill [Roll Forward]
Goodwill, beginning balance			9,662
Effect of foreign currency exchange rates			(379)
Goodwill, ending balance	9,283		9,283
Genesco Brands Group
Goodwill [Roll Forward]
Goodwill, beginning balance			28,461
Impairment			(28,453)
Effect of foreign currency exchange rates			(8)
Goodwill, ending balance	$ 0		$ 0

[1] (2) Goodwill impairment of $28.5 million is related to Genesco Brands Group.

XML

Goodwill and Other Intangible Assets - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Oct. 28, 2023	Jul. 29, 2023	Oct. 29, 2022	Oct. 28, 2023		Oct. 29, 2022
Acquired Finite-Lived Intangible Assets [Line Items]
Goodwill impairment charge	$ 0		$ 0	$ 28,453	[1]	$ 0
Genesco Brands Group
Acquired Finite-Lived Intangible Assets [Line Items]
Percentage of estimated impairment				50.00%
Goodwill impairment charge		$ 28,500		$ 28,500

[1] (2) Goodwill impairment of $28.5 million is related to Genesco Brands Group.

XML

Goodwill and Other Intangible Assets - Summary of Other Intangibles Assets (Details) - USD ($) $ in Thousands	Oct. 28, 2023	Jan. 28, 2023	Oct. 29, 2022
Other intangibles by major classes
Gross other intangibles	$ 30,359	$ 30,952
Accumulated amortization	(3,917)	(3,522)
Net Other Intangibles	26,442	27,430	$ 26,208
Trademarks
Other intangibles by major classes
Gross other intangibles	23,514	24,077
Accumulated amortization	0	0
Net Other Intangibles	23,514	24,077
Customer Lists
Other intangibles by major classes
Gross other intangibles	6,445	6,475
Accumulated amortization	(3,517)	(3,122)
Net Other Intangibles	2,928	3,353
Other
Other intangibles by major classes
Gross other intangibles	400	400
Accumulated amortization	(400)	(400)
Net Other Intangibles	$ 0	$ 0

XML

Asset Impairments and Other Charges - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Oct. 28, 2023		Oct. 29, 2022	Oct. 28, 2023		Oct. 29, 2022
Restructuring Cost And Reserve [Line Items]
Asset impairments and other, net	$ (99)	[1]	$ 0	$ (581)	[2]	$ 154	[3]

[1] Asset impairments and other includes a $0.1 million charge for asset impairments in Journeys Group.

[2] (3) Asset impairments and other includes a $0.6 million charge for asset impairments in Journeys Group.

[3] (2) Asset impairments and other includes a $0.5 million charge for asset impairments, which includes $0.2 million in Journeys Group, $0.2 million in Schuh Group and $0.1 million in Genesco Brands Group, partially offset by a $0.7 million gain on the termination of the pension plan.

XML

Inventories - Schedule of Inventories (Details) - USD ($) $ in Thousands	Oct. 28, 2023	Jan. 28, 2023	Oct. 29, 2022
Inventories
Wholesale finished goods	$ 61,571	$ 84,209
Retail merchandise	455,164	373,808
Total Inventories	$ 516,735	$ 458,017	$ 563,490

XML

Fair Value - Schedule of Fair Values of Financial Instruments (Details) - USD ($) $ in Thousands	Oct. 28, 2023	Jan. 28, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Amount	$ 128,163	$ 44,858
Fair Value	128,529	45,083
U.S. Revolver Borrowings
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Amount	122,101	30,000
Fair Value	122,465	30,219
U.K. Revolver Borrowings
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Amount	6,062	14,858
Fair Value	$ 6,064	$ 14,864

XML

Fair Value - Additional Information (Details) - USD ($) $ in Millions	Oct. 28, 2023	Oct. 29, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long-lived assets	$ 704.5	$ 704.6
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long-lived assets	0.8
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments held	$ 5.8

XML

Earnings Per Share - Summary of Weighted-Average Number of Shares (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Oct. 28, 2023	Oct. 29, 2022	Oct. 28, 2023	Oct. 29, 2022
Earnings Per Share [Abstract]
Weighted-average number of shares - basic	10,898	12,138	11,353	12,637
Common stock equivalents	74	188	0	264
Weighted-average number of shares - diluted	10,972	12,326	11,353	12,901

XML

Earnings Per Share - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	3 Months Ended						9 Months Ended
	Dec. 06, 2023	Oct. 28, 2023	Jul. 29, 2023	Apr. 29, 2023	Oct. 29, 2022	Jul. 30, 2022	Apr. 30, 2022	Oct. 28, 2023	Oct. 29, 2022	Jan. 29, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Common stock equivalents excluded								120,000
Stock repurchased during period (in shares)		0			451,343			1,261,295	1,380,272
Shares repurchased			$ 22,857	$ 9,170	$ 20,768	$ 45,422	$ 6,500	$ 32,000	$ 72,700
Share price					$ 46.01			$ 25.39	$ 52.66
Stock repurchase accrued amount										$ 4,800
Remaining authorized repurchase amount		$ 52,100						$ 52,100
Subsequent Event [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Stock repurchased during period (in shares)	0

XML

Long-Term Debt - Schedule of Long-Term Debt (Details) - USD ($) $ in Thousands	Oct. 28, 2023	Jan. 28, 2023	Oct. 29, 2022
Debt Instrument [Line Items]
Total long-term debt	$ 128,163	$ 44,858
Current portion	0	0	$ 3,484
Total Noncurrent Portion of Long-Term Debt	128,163	44,858	$ 85,904
U.S. revolver borrowings
Debt Instrument [Line Items]
Total long-term debt	122,101	30,000
U.K. revolver borrowings
Debt Instrument [Line Items]
Total long-term debt	$ 6,062	$ 14,858

XML

Long-Term Debt - Additional Information (Details) $ in Thousands, £ in Millions, $ in Millions	9 Months Ended
	Oct. 28, 2023 USD ($)	Oct. 28, 2023 CAD ($)	Oct. 28, 2023 GBP (£)	Jan. 28, 2023 USD ($)
Debt Instrument [Line Items]
Carrying Amount	$ 128,163			$ 44,858
Long term debt description	The revolver borrowings outstanding under the Credit Facility as of October 28, 2023 included $117.2 million U.S. revolver borrowings and $4.9 million (C$6.8 million) related to GCO Canada ULC. In addition, revolver borrowings outstanding under the Facility Agreement were $6.1 million (£5.0 million). We were in compliance with all the relevant terms and conditions of the Credit Facility and Facility Agreement as of October 28, 2023. Excess availability under the Credit Facility was $203.4 million at October 28, 2023.
Revolving Credit Facility
Debt Instrument [Line Items]
Excess availability under credit facility	$ 203,400
Genesco Canada Ulc | Revolving Credit Facility
Debt Instrument [Line Items]
Carrying Amount	4,900	$ 6.8
U.S. Revolver Borrowings
Debt Instrument [Line Items]
Carrying Amount	122,101			$ 30,000
U.S. Revolver Borrowings | Revolving Credit Facility
Debt Instrument [Line Items]
Carrying Amount	117,200
Facility Agreement | Revolving Credit Facility
Debt Instrument [Line Items]
Carrying Amount	$ 6,100		£ 5.0

XML

Legal Proceedings - Additional Information (Details) - USD ($) $ in Millions	Oct. 28, 2023	Jan. 28, 2023	Oct. 29, 2022
Loss Contingencies [Line Items]
Amount related to outstanding environmental contingencies	$ 1.6	$ 1.7	$ 1.4

XML

Commitments - Additional Information (Details) $ in Millions	Oct. 28, 2023 USD ($)
Samsung
Loss Contingencies [Line Items]
Historical cost of inventory	$ 14.4

XML

Business Segment Information - Schedule of Business Segment Information (Details) - USD ($) $ in Thousands		3 Months Ended					9 Months Ended
		Oct. 28, 2023		Jul. 29, 2023	Oct. 29, 2022		Oct. 28, 2023		Oct. 29, 2022		Jan. 28, 2023
Segment Reporting Information [Line Items]
Net sales		$ 579,315	[1]		$ 603,788	[2]	$ 1,585,674	[3]	$ 1,659,868	[4]
Segment operating income (loss)		10,951					(21,738)		43,247
Goodwill impairment		0			0		28,453	[5]	0
Asset impairments and other		99	[6]		0		581	[7]	(154)	[8]
Operating income (loss)		10,852			26,073		(50,772)		43,401
Other components of net periodic benefit cost		148			50		388		198
Interest expense, net		2,207			906		6,241		1,608
Earnings (loss) from continuing operations before income taxes		8,497			25,117		(57,401)		41,595
Total assets		1,492,931	[9]		1,536,993	[10]	1,492,931	[9]	1,536,993	[10]	$ 1,456,426
Depreciation and amortization		12,330			10,672		35,449		31,901
Capital expenditures		14,440			10,840		49,738		39,845
Journeys Group
Segment Reporting Information [Line Items]
Net sales		349,367	[1]		380,619	[2]	908,832	[3]	1,016,396	[4]
Schuh Group
Segment Reporting Information [Line Items]
Net sales		118,129	[1]		104,809	[2]	334,033	[3]	294,486	[4]
Johnston & Murphy Group
Segment Reporting Information [Line Items]
Net sales		81,411	[1]		79,614	[2]	241,823	[3]	225,448	[4]
Genesco Brands Group
Segment Reporting Information [Line Items]
Net sales		30,408	[1]		38,746	[2]	100,986	[3]	123,538	[4]
Goodwill impairment				$ 28,500			28,500
Operating Segments
Segment Reporting Information [Line Items]
Net sales		581,817			605,703		1,588,929		1,662,772
Operating Segments | Journeys Group
Segment Reporting Information [Line Items]
Net sales		349,367			380,619		908,832		1,016,396
Segment operating income (loss)		11,975					(21,265)		51,235
Goodwill impairment	[5]						0
Asset impairments and other		0	[6]				0	[7]	0	[8]
Operating income (loss)		11,975			27,083		(21,265)		51,235
Other components of net periodic benefit cost		0			0		0		0
Interest expense, net		0			0		0		0
Earnings (loss) from continuing operations before income taxes		11,975			27,083		(21,265)		51,235
Total assets		798,968	[9]		841,021	[10]	798,968	[9]	841,021	[10]
Depreciation and amortization		8,078			6,849		23,235		21,060
Capital expenditures		8,235			4,638		32,447		15,539
Operating Segments | Schuh Group
Segment Reporting Information [Line Items]
Net sales		118,129			104,809		334,033		294,486
Segment operating income (loss)		5,484					12,110		5,260
Goodwill impairment	[5]						0
Asset impairments and other		0	[6]				0	[7]	0	[8]
Operating income (loss)		5,484			5,912		12,110		5,260
Other components of net periodic benefit cost		0			0		0		0
Interest expense, net		0			0		0		0
Earnings (loss) from continuing operations before income taxes		5,484			5,912		12,110		5,260
Total assets		213,036	[9]		206,996	[10]	213,036	[9]	206,996	[10]
Depreciation and amortization		1,566			1,485		4,751		4,607
Capital expenditures		3,380			2,405		9,376		6,278
Operating Segments | Johnston & Murphy Group
Segment Reporting Information [Line Items]
Net sales		81,414			79,614		241,832		225,448
Segment operating income (loss)		2,706					10,178		7,256
Goodwill impairment	[5]						0
Asset impairments and other		0	[6]				0	[7]	0	[8]
Operating income (loss)		2,706			3,494		10,178		7,256
Other components of net periodic benefit cost		0			0		0		0
Interest expense, net		0			0		0		0
Earnings (loss) from continuing operations before income taxes		2,706			3,494		10,178		7,256
Total assets		185,179	[9]		193,039	[10]	185,179	[9]	193,039	[10]
Depreciation and amortization		1,365			1,092		3,622		3,271
Capital expenditures		1,975			1,719		5,277		5,528
Operating Segments | Genesco Brands Group
Segment Reporting Information [Line Items]
Net sales		32,907			40,661		104,232		126,442
Segment operating income (loss)		(1,560)					259		2,551
Goodwill impairment	[5]						0
Asset impairments and other		0	[6]				0	[7]	0	[8]
Operating income (loss)		(1,560)			(1,927)		259		2,551
Other components of net periodic benefit cost		0			0		0		0
Interest expense, net		0			0		0		0
Earnings (loss) from continuing operations before income taxes		(1,560)			(1,927)		259		2,551
Total assets		52,170	[9]		72,586	[10]	52,170	[9]	72,586	[10]
Depreciation and amortization		265			214		669		692
Capital expenditures		710			370		1,788		1,033
Corporate & Other
Segment Reporting Information [Line Items]
Net sales		0	[1]		0	[2]	0	[3]	0	[4]
Segment operating income (loss)		(7,654)					(23,020)		(23,055)
Goodwill impairment	[5]						28,453
Asset impairments and other		99	[6]				581	[7]	(154)	[8]
Operating income (loss)		(7,753)			(8,489)		(52,054)		(22,901)
Other components of net periodic benefit cost		148			50		388		198
Interest expense, net		2,207			906		6,241		1,608
Earnings (loss) from continuing operations before income taxes		(10,108)			(9,445)		(58,683)		(24,707)
Total assets		243,578	[9]		223,351	[10]	243,578	[9]	223,351	[10]
Depreciation and amortization		1,056			1,032		3,172		2,271
Capital expenditures		140			1,708		850		11,467
Intercompany Sales
Segment Reporting Information [Line Items]
Net sales		(2,502)			(1,915)		(3,255)		(2,904)
Intercompany Sales | Journeys Group
Segment Reporting Information [Line Items]
Net sales		0			0		0		0
Intercompany Sales | Schuh Group
Segment Reporting Information [Line Items]
Net sales		0			0		0		0
Intercompany Sales | Johnston & Murphy Group
Segment Reporting Information [Line Items]
Net sales		(3)			0		(9)		0
Intercompany Sales | Genesco Brands Group
Segment Reporting Information [Line Items]
Net sales		$ (2,499)			$ (1,915)		$ (3,246)		$ (2,904)

[1] Net sales in North America and in the U.K., which includes the ROI, accounted for 80% and 20%, respectively, of our net sales in the third quarter of Fiscal 2024.

[2] Net sales in North America and in the U.K., which includes the ROI, accounted for 83% and 17%, respectively, of our net sales for the third quarter of Fiscal 2023.

[3] (1) Net sales in North America and in the U.K., which includes the ROI, accounted for 79% and 21%, respectively, of our net sales in the first nine months of Fiscal 2024.

[4] (1) Net sales in North America and in the U.K., which includes the ROI, accounted for 82% and 18%, respectively, of our net sales for the first nine months of Fiscal 2023.

[5] (2) Goodwill impairment of $28.5 million is related to Genesco Brands Group.

[6] Asset impairments and other includes a $0.1 million charge for asset impairments in Journeys Group.

[7] (3) Asset impairments and other includes a $0.6 million charge for asset impairments in Journeys Group.

[8] (2) Asset impairments and other includes a $0.5 million charge for asset impairments, which includes $0.2 million in Journeys Group, $0.2 million in Schuh Group and $0.1 million in Genesco Brands Group, partially offset by a $0.7 million gain on the termination of the pension plan.

[9] Of our $704.5 million of long-lived assets, $87.9 million and $12.9 million relate to long-lived assets in the U.K. and Canada, respectively.

[10] (2) Of our $704.6 million of long-lived assets, $89.3 million and $18.5 million relate to long-lived assets in the U.K. and Canada, respectively.

XML

Business Segment Information - Schedule of Business Segment Information (Parenthetical) (Details) - USD ($) $ in Thousands	3 Months Ended				9 Months Ended
	Oct. 28, 2023		Jul. 29, 2023	Oct. 29, 2022	Oct. 28, 2023		Oct. 29, 2022
Segment Reporting Information [Line Items]
Asset impairments and other, net	$ 99	[1]		$ 0	$ 581	[2]	$ (154)	[3]
Long-lived assets	704,500			704,600	704,500		704,600
Goodwill impairment	0			0	28,453	[4]	0
U.K.
Segment Reporting Information [Line Items]
Long-lived assets	87,900			89,300	87,900		89,300
Canada
Segment Reporting Information [Line Items]
Long-lived assets	$ 12,900			$ 18,500	$ 12,900		$ 18,500
GeographicConcentrationRiskMember | SalesRevenueNetMember | U.K.
Segment Reporting Information [Line Items]
ConcentrationRiskPercentage1	20.00%			17.00%	21.00%		18.00%
GeographicConcentrationRiskMember | SalesRevenueNetMember | NorthAmerica
Segment Reporting Information [Line Items]
ConcentrationRiskPercentage1	80.00%			83.00%	79.00%		82.00%
Genesco Brands Group
Segment Reporting Information [Line Items]
Goodwill impairment			$ 28,500		$ 28,500
Retail Store Asset Impairments
Segment Reporting Information [Line Items]
Asset impairments and other, net							$ (500)
Retail Store Asset Impairments | Journeys Group
Segment Reporting Information [Line Items]
Asset impairments and other, net	$ (100)				$ (600)		(200)
Retail Store Asset Impairments | Schuh Group
Segment Reporting Information [Line Items]
Asset impairments and other, net							(200)
Retail Store Asset Impairments | Genesco Brands Group
Segment Reporting Information [Line Items]
Asset impairments and other, net							(100)
Gain on the Termination of the Pension Plan
Segment Reporting Information [Line Items]
Asset impairments and other, net							$ (700)

[1] Asset impairments and other includes a $0.1 million charge for asset impairments in Journeys Group.

[2] (3) Asset impairments and other includes a $0.6 million charge for asset impairments in Journeys Group.

[3] (2) Asset impairments and other includes a $0.5 million charge for asset impairments, which includes $0.2 million in Journeys Group, $0.2 million in Schuh Group and $0.1 million in Genesco Brands Group, partially offset by a $0.7 million gain on the termination of the pension plan.

[4] (2) Goodwill impairment of $28.5 million is related to Genesco Brands Group.